Gene Symbol | Gene ID | Gene Info |
---|---|---|
SP4
|
ENSG00000105866.9 | Sp4 transcription factor |
PML
|
ENSG00000140464.15 | PML nuclear body scaffold |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr15_74333289_74333462 | PML | 16154 | 0.138021 | 0.78 | 1.4e-02 | Click! |
chr15_74290143_74290294 | PML | 3074 | 0.196867 | 0.77 | 1.5e-02 | Click! |
chr15_74304230_74304381 | PML | 10948 | 0.152119 | 0.63 | 6.8e-02 | Click! |
chr15_74333685_74333836 | PML | 16539 | 0.137216 | 0.61 | 7.9e-02 | Click! |
chr15_74303888_74304052 | PML | 11283 | 0.151450 | 0.53 | 1.4e-01 | Click! |
chr7_21472009_21472160 | SP4 | 4423 | 0.218089 | -0.77 | 1.5e-02 | Click! |
chr7_21471488_21471682 | SP4 | 3924 | 0.226600 | -0.75 | 1.9e-02 | Click! |
chr7_21470822_21470973 | SP4 | 3236 | 0.244610 | -0.68 | 4.5e-02 | Click! |
chr7_21470215_21470407 | SP4 | 2650 | 0.270533 | -0.67 | 4.8e-02 | Click! |
chr7_21471147_21471369 | SP4 | 3597 | 0.233998 | -0.62 | 7.3e-02 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr1_14924992_14926197 | 20.80 |
KAZN |
kazrin, periplakin interacting protein |
381 |
0.93 |
chr10_79396627_79397649 | 16.61 |
KCNMA1 |
potassium large conductance calcium-activated channel, subfamily M, alpha member 1 |
67 |
0.98 |
chr6_72129322_72130506 | 12.68 |
ENSG00000207827 |
. |
16590 |
0.22 |
chr1_180881914_180882730 | 12.53 |
KIAA1614 |
KIAA1614 |
3 |
0.98 |
chr22_43115644_43116713 | 12.47 |
A4GALT |
alpha 1,4-galactosyltransferase |
24539 |
0.15 |
chr2_242497891_242499073 | 12.28 |
BOK-AS1 |
BOK antisense RNA 1 |
90 |
0.79 |
chr7_45002030_45002849 | 10.14 |
RP4-647J21.1 |
|
1931 |
0.25 |
chr17_37856067_37857084 | 10.07 |
ERBB2 |
v-erb-b2 avian erythroblastic leukemia viral oncogene homolog 2 |
242 |
0.86 |
chr2_160918347_160919586 | 9.72 |
PLA2R1 |
phospholipase A2 receptor 1, 180kDa |
155 |
0.98 |
chr5_63461313_63462499 | 9.72 |
RNF180 |
ring finger protein 180 |
83 |
0.99 |
chr7_95401616_95402462 | 9.56 |
DYNC1I1 |
dynein, cytoplasmic 1, intermediate chain 1 |
123 |
0.98 |
chr17_59476045_59476898 | 9.52 |
RP11-332H18.4 |
|
260 |
0.74 |
chr1_110693132_110693795 | 9.41 |
SLC6A17 |
solute carrier family 6 (neutral amino acid transporter), member 17 |
355 |
0.81 |
chrX_132548696_132549413 | 9.28 |
GPC4 |
glypican 4 |
464 |
0.88 |
chr15_48937037_48938293 | 9.05 |
FBN1 |
fibrillin 1 |
253 |
0.95 |
chr16_85203170_85204140 | 8.81 |
CTC-786C10.1 |
|
1227 |
0.55 |
chr2_54086905_54087527 | 8.80 |
GPR75-ASB3 |
GPR75-ASB3 readthrough |
46 |
0.37 |
chr2_127976513_127977351 | 8.75 |
CYP27C1 |
cytochrome P450, family 27, subfamily C, polypeptide 1 |
722 |
0.74 |
chr1_65991038_65991651 | 8.68 |
RP4-630A11.3 |
|
39255 |
0.14 |
chr15_73976688_73977423 | 8.65 |
CD276 |
CD276 molecule |
17 |
0.98 |
chr13_27131903_27132772 | 8.53 |
WASF3 |
WAS protein family, member 3 |
450 |
0.89 |
chr2_167232459_167233133 | 8.48 |
SCN9A |
sodium channel, voltage-gated, type IX, alpha subunit |
293 |
0.93 |
chrX_110038687_110039773 | 8.33 |
CHRDL1 |
chordin-like 1 |
56 |
0.99 |
chr8_69242814_69243988 | 8.28 |
C8orf34 |
chromosome 8 open reading frame 34 |
56 |
0.82 |
chr11_70244216_70245100 | 8.24 |
CTTN |
cortactin |
11 |
0.53 |
chr9_71939475_71940274 | 8.17 |
FAM189A2 |
family with sequence similarity 189, member A2 |
386 |
0.91 |
chr5_78985270_78986298 | 8.11 |
CMYA5 |
cardiomyopathy associated 5 |
84 |
0.98 |
chr9_113341179_113342041 | 8.08 |
SVEP1 |
sushi, von Willebrand factor type A, EGF and pentraxin domain containing 1 |
213 |
0.96 |
chr20_49347136_49348386 | 8.07 |
PARD6B |
par-6 family cell polarity regulator beta |
320 |
0.89 |
chr9_130159461_130160475 | 7.98 |
SLC2A8 |
solute carrier family 2 (facilitated glucose transporter), member 8 |
305 |
0.87 |
chr22_41633466_41634617 | 7.92 |
CHADL |
chondroadherin-like |
1584 |
0.26 |
chr16_75284494_75285397 | 7.83 |
BCAR1 |
breast cancer anti-estrogen resistance 1 |
100 |
0.96 |
chr17_34611752_34612896 | 7.83 |
CCL3L1 |
chemokine (C-C motif) ligand 3-like 1 |
13395 |
0.14 |
chr11_57365224_57366004 | 7.80 |
SERPING1 |
serpin peptidase inhibitor, clade G (C1 inhibitor), member 1 |
338 |
0.8 |
chr5_1110808_1112337 | 7.79 |
SLC12A7 |
solute carrier family 12 (potassium/chloride transporter), member 7 |
578 |
0.75 |
chr9_140500205_140501463 | 7.76 |
ARRDC1 |
arrestin domain containing 1 |
679 |
0.56 |
chr1_112532383_112532987 | 7.76 |
KCND3 |
potassium voltage-gated channel, Shal-related subfamily, member 3 |
908 |
0.69 |
chr2_149894818_149895436 | 7.71 |
LYPD6B |
LY6/PLAUR domain containing 6B |
105 |
0.98 |
chr9_132382165_132382732 | 7.64 |
C9orf50 |
chromosome 9 open reading frame 50 |
607 |
0.62 |
chr17_76164337_76165654 | 7.61 |
SYNGR2 |
synaptogyrin 2 |
244 |
0.87 |
chr22_19165246_19166141 | 7.58 |
SLC25A1 |
solute carrier family 25 (mitochondrial carrier; citrate transporter), member 1 |
341 |
0.82 |
chr12_7037386_7038830 | 7.45 |
ATN1 |
atrophin 1 |
632 |
0.41 |
chr9_127539201_127540134 | 7.44 |
OLFML2A |
olfactomedin-like 2A |
117 |
0.95 |
chr4_150999769_151000790 | 7.43 |
DCLK2 |
doublecortin-like kinase 2 |
99 |
0.98 |
chr7_108095607_108096848 | 7.35 |
NRCAM |
neuronal cell adhesion molecule |
538 |
0.84 |
chr1_178063035_178063602 | 7.31 |
RASAL2 |
RAS protein activator like 2 |
42 |
0.99 |
chr11_131780761_131781452 | 7.28 |
NTM |
neurotrimin |
209 |
0.95 |
chr12_3308931_3310293 | 7.27 |
TSPAN9 |
tetraspanin 9 |
729 |
0.75 |
chr17_20491916_20492779 | 7.23 |
CDRT15L2 |
CMT1A duplicated region transcript 15-like 2 |
9310 |
0.21 |
chr9_23821130_23821679 | 7.17 |
ELAVL2 |
ELAV like neuron-specific RNA binding protein 2 |
74 |
0.99 |
chr16_2521208_2521831 | 7.15 |
NTN3 |
netrin 3 |
19 |
0.93 |
chr6_54711000_54712080 | 7.14 |
FAM83B |
family with sequence similarity 83, member B |
29 |
0.98 |
chr3_126702505_126703684 | 7.12 |
PLXNA1 |
plexin A1 |
4343 |
0.34 |
chr20_4229911_4230312 | 7.09 |
ADRA1D |
adrenoceptor alpha 1D |
390 |
0.89 |
chr3_192126971_192127690 | 7.06 |
FGF12 |
fibroblast growth factor 12 |
492 |
0.87 |
chr5_174178214_174178699 | 7.05 |
ENSG00000266890 |
. |
281 |
0.94 |
chr9_35489468_35490886 | 7.02 |
RUSC2 |
RUN and SH3 domain containing 2 |
53 |
0.97 |
chr7_29846053_29846716 | 7.00 |
WIPF3 |
WAS/WASL interacting protein family, member 3 |
282 |
0.94 |
chrX_83442690_83443328 | 6.97 |
RPS6KA6 |
ribosomal protein S6 kinase, 90kDa, polypeptide 6 |
76 |
0.98 |
chr6_88875424_88876640 | 6.95 |
CNR1 |
cannabinoid receptor 1 (brain) |
46 |
0.99 |
chr1_231297648_231298418 | 6.94 |
TRIM67 |
tripartite motif containing 67 |
175 |
0.95 |
chr2_239072349_239072829 | 6.89 |
FAM132B |
family with sequence similarity 132, member B |
385 |
0.8 |
chr18_25757173_25757741 | 6.86 |
CDH2 |
cadherin 2, type 1, N-cadherin (neuronal) |
47 |
0.99 |
chr10_21462508_21463481 | 6.86 |
NEBL-AS1 |
NEBL antisense RNA 1 |
51 |
0.59 |
chr10_18429523_18430148 | 6.86 |
CACNB2 |
calcium channel, voltage-dependent, beta 2 subunit |
52 |
0.99 |
chr14_38063567_38064244 | 6.82 |
FOXA1 |
forkhead box A1 |
334 |
0.84 |
chr2_113956230_113956830 | 6.80 |
PSD4 |
pleckstrin and Sec7 domain containing 4 |
2673 |
0.2 |
chr18_6729547_6730123 | 6.76 |
ARHGAP28 |
Rho GTPase activating protein 28 |
14 |
0.5 |
chr4_75718841_75720131 | 6.75 |
BTC |
betacellulin |
410 |
0.91 |
chr11_27740485_27740934 | 6.74 |
BDNF |
brain-derived neurotrophic factor |
585 |
0.82 |
chr2_243030793_243031816 | 6.72 |
AC093642.5 |
|
460 |
0.62 |
chr2_71127433_71128165 | 6.70 |
VAX2 |
ventral anterior homeobox 2 |
79 |
0.96 |
chr2_79739509_79740065 | 6.63 |
CTNNA2 |
catenin (cadherin-associated protein), alpha 2 |
339 |
0.91 |
chr7_100464814_100466140 | 6.63 |
TRIP6 |
thyroid hormone receptor interactor 6 |
717 |
0.47 |
chr9_17578628_17579355 | 6.61 |
SH3GL2 |
SH3-domain GRB2-like 2 |
130 |
0.98 |
chr11_111169649_111170452 | 6.60 |
COLCA2 |
colorectal cancer associated 2 |
74 |
0.88 |
chr10_79397825_79398297 | 6.55 |
KCNMA1 |
potassium large conductance calcium-activated channel, subfamily M, alpha member 1 |
66 |
0.98 |
chr17_7284064_7284762 | 6.54 |
TNK1 |
tyrosine kinase, non-receptor, 1 |
48 |
0.92 |
chr15_51633704_51634417 | 6.52 |
GLDN |
gliomedin |
234 |
0.91 |
chr14_69726344_69726819 | 6.52 |
GALNT16 |
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 16 |
100 |
0.98 |
chr5_121647834_121648295 | 6.49 |
SNCAIP |
synuclein, alpha interacting protein |
132 |
0.9 |
chr7_89841111_89841428 | 6.49 |
STEAP2 |
STEAP family member 2, metalloreductase |
24 |
0.82 |
chr19_55684291_55685412 | 6.47 |
SYT5 |
synaptotagmin V |
1083 |
0.28 |
chr1_934275_935357 | 6.43 |
HES4 |
hes family bHLH transcription factor 4 |
545 |
0.57 |
chr6_5084934_5086227 | 6.41 |
PPP1R3G |
protein phosphatase 1, regulatory subunit 3G |
140 |
0.97 |
chr10_128594353_128594780 | 6.41 |
DOCK1 |
dedicator of cytokinesis 1 |
588 |
0.8 |
chr5_129240122_129240866 | 6.40 |
CHSY3 |
chondroitin sulfate synthase 3 |
329 |
0.79 |
chr15_47476270_47477144 | 6.37 |
SEMA6D |
sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6D |
409 |
0.87 |
chr11_503866_504897 | 6.36 |
RNH1 |
ribonuclease/angiogenin inhibitor 1 |
171 |
0.89 |
chr12_80083529_80084306 | 6.35 |
PAWR |
PRKC, apoptosis, WT1, regulator |
57 |
0.98 |
chr19_6740138_6741070 | 6.32 |
TRIP10 |
thyroid hormone receptor interactor 10 |
325 |
0.81 |
chr12_106532817_106533194 | 6.32 |
NUAK1 |
NUAK family, SNF1-like kinase, 1 |
806 |
0.7 |
chr2_218843405_218844030 | 6.30 |
TNS1 |
tensin 1 |
60 |
0.79 |
chr10_118764443_118765166 | 6.26 |
KIAA1598 |
KIAA1598 |
72 |
0.98 |
chrX_102318388_102319159 | 6.19 |
BEX1 |
brain expressed, X-linked 1 |
395 |
0.83 |
chr18_52626293_52626952 | 6.17 |
CCDC68 |
coiled-coil domain containing 68 |
117 |
0.97 |
chr2_236401822_236402641 | 6.16 |
AGAP1 |
ArfGAP with GTPase domain, ankyrin repeat and PH domain 1 |
502 |
0.83 |
chr14_70346080_70346697 | 6.16 |
SMOC1 |
SPARC related modular calcium binding 1 |
245 |
0.95 |
chr19_34972837_34973110 | 6.14 |
WTIP |
Wilms tumor 1 interacting protein |
430 |
0.8 |
chr5_31193803_31195028 | 6.11 |
CDH6 |
cadherin 6, type 2, K-cadherin (fetal kidney) |
558 |
0.85 |
chr19_41073613_41074217 | 6.11 |
SHKBP1 |
SH3KBP1 binding protein 1 |
8842 |
0.14 |
chr1_241520119_241520816 | 6.11 |
RGS7 |
regulator of G-protein signaling 7 |
63 |
0.99 |
chr11_110582275_110583137 | 6.11 |
ARHGAP20 |
Rho GTPase activating protein 20 |
67 |
0.99 |
chr22_50745196_50745796 | 6.09 |
PLXNB2 |
plexin B2 |
521 |
0.61 |
chr19_14315927_14317134 | 6.08 |
LPHN1 |
latrophilin 1 |
451 |
0.77 |
chr3_173114984_173115853 | 6.06 |
NLGN1 |
neuroligin 1 |
152 |
0.98 |
chr12_112818867_112820166 | 6.02 |
HECTD4 |
HECT domain containing E3 ubiquitin protein ligase 4 |
380 |
0.87 |
chr20_23617810_23618640 | 6.01 |
CST3 |
cystatin C |
357 |
0.87 |
chr15_83875578_83876391 | 5.98 |
HDGFRP3 |
Hepatoma-derived growth factor-related protein 3 |
786 |
0.64 |
chr3_33318777_33319866 | 5.96 |
FBXL2 |
F-box and leucine-rich repeat protein 2 |
353 |
0.91 |
chr17_29036450_29037561 | 5.96 |
ENSG00000241631 |
. |
7212 |
0.17 |
chr7_150779695_150780926 | 5.96 |
TMUB1 |
transmembrane and ubiquitin-like domain containing 1 |
9 |
0.94 |
chr2_159825200_159826543 | 5.95 |
TANC1 |
tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1 |
688 |
0.73 |
chr6_19838575_19839711 | 5.92 |
RP1-167F1.2 |
|
168 |
0.95 |
chr22_37956672_37957106 | 5.91 |
CDC42EP1 |
CDC42 effector protein (Rho GTPase binding) 1 |
402 |
0.77 |
chr1_15480157_15480820 | 5.87 |
TMEM51 |
transmembrane protein 51 |
203 |
0.95 |
chrX_12156590_12157176 | 5.84 |
FRMPD4 |
FERM and PDZ domain containing 4 |
298 |
0.9 |
chr12_45444664_45445224 | 5.83 |
DBX2 |
developing brain homeobox 2 |
62 |
0.76 |
chr5_54179266_54180220 | 5.81 |
ENSG00000221073 |
. |
30967 |
0.19 |
chr17_77019963_77021139 | 5.78 |
C1QTNF1 |
C1q and tumor necrosis factor related protein 1 |
208 |
0.91 |
chr2_191044944_191045899 | 5.77 |
C2orf88 |
chromosome 2 open reading frame 88 |
168 |
0.96 |
chr6_166721057_166722024 | 5.77 |
PRR18 |
proline rich 18 |
331 |
0.9 |
chr12_71003154_71004126 | 5.75 |
PTPRB |
protein tyrosine phosphatase, receptor type, B |
16 |
0.99 |
chr9_110250307_110251795 | 5.75 |
KLF4 |
Kruppel-like factor 4 (gut) |
360 |
0.89 |
chr9_113800702_113801367 | 5.74 |
LPAR1 |
lysophosphatidic acid receptor 1 |
53 |
0.98 |
chr19_1566819_1567637 | 5.69 |
MEX3D |
mex-3 RNA binding family member D |
301 |
0.76 |
chr12_29936821_29937292 | 5.68 |
TMTC1 |
transmembrane and tetratricopeptide repeat containing 1 |
226 |
0.96 |
chr6_159239962_159240825 | 5.67 |
EZR |
ezrin |
51 |
0.96 |
chr6_118228401_118229053 | 5.66 |
SLC35F1 |
solute carrier family 35, member F1 |
38 |
0.99 |
chr4_55096373_55096991 | 5.66 |
PDGFRA |
platelet-derived growth factor receptor, alpha polypeptide |
193 |
0.97 |
chr16_55542879_55544136 | 5.65 |
LPCAT2 |
lysophosphatidylcholine acyltransferase 2 |
597 |
0.77 |
chr16_691284_692401 | 5.65 |
FAM195A |
family with sequence similarity 195, member A |
29 |
0.92 |
chr19_13906290_13907522 | 5.64 |
ZSWIM4 |
zinc finger, SWIM-type containing 4 |
632 |
0.39 |
chr4_157997366_157997978 | 5.63 |
GLRB |
glycine receptor, beta |
117 |
0.97 |
chr9_86152792_86153773 | 5.63 |
FRMD3 |
FERM domain containing 3 |
71 |
0.98 |
chr6_147829082_147829740 | 5.62 |
SAMD5 |
sterile alpha motif domain containing 5 |
652 |
0.84 |
chr5_38846105_38846894 | 5.62 |
OSMR |
oncostatin M receptor |
398 |
0.91 |
chr16_14396121_14396821 | 5.62 |
ENSG00000207639 |
. |
1353 |
0.42 |
chr13_93879365_93880233 | 5.61 |
GPC6 |
glypican 6 |
704 |
0.82 |
chr8_15094580_15095009 | 5.58 |
SGCZ |
sarcoglycan, zeta |
1054 |
0.7 |
chr17_21279729_21280949 | 5.57 |
KCNJ12 |
potassium inwardly-rectifying channel, subfamily J, member 12 |
830 |
0.69 |
chr6_117086060_117086951 | 5.57 |
FAM162B |
family with sequence similarity 162, member B |
381 |
0.87 |
chr8_15397591_15398115 | 5.56 |
TUSC3 |
tumor suppressor candidate 3 |
61 |
0.98 |
chr11_120195755_120196855 | 5.55 |
TMEM136 |
transmembrane protein 136 |
289 |
0.9 |
chr16_2517636_2518674 | 5.55 |
RP11-715J22.2 |
|
59 |
0.92 |
chr10_101088892_101089952 | 5.52 |
CNNM1 |
cyclin M1 |
266 |
0.95 |
chr1_220701624_220702485 | 5.51 |
MARK1 |
MAP/microtubule affinity-regulating kinase 1 |
155 |
0.97 |
chr18_11149170_11149978 | 5.51 |
PIEZO2 |
piezo-type mechanosensitive ion channel component 2 |
987 |
0.72 |
chr1_33207592_33208218 | 5.51 |
KIAA1522 |
KIAA1522 |
419 |
0.8 |
chr4_169753076_169754370 | 5.50 |
RP11-635L1.3 |
|
365 |
0.61 |
chr15_56034170_56035376 | 5.47 |
PRTG |
protogenin |
41 |
0.98 |
chr6_19838100_19838453 | 5.46 |
ID4 |
inhibitor of DNA binding 4, dominant negative helix-loop-helix protein |
659 |
0.6 |
chr6_78172796_78173983 | 5.46 |
HTR1B |
5-hydroxytryptamine (serotonin) receptor 1B, G protein-coupled |
101 |
0.99 |
chr9_21974540_21975658 | 5.45 |
CDKN2A |
cyclin-dependent kinase inhibitor 2A |
2 |
0.97 |
chr16_85269227_85269622 | 5.44 |
CTC-786C10.1 |
|
64542 |
0.11 |
chr19_41725215_41725482 | 5.43 |
AXL |
AXL receptor tyrosine kinase |
208 |
0.89 |
chr9_103235708_103236480 | 5.42 |
TMEFF1 |
transmembrane protein with EGF-like and two follistatin-like domains 1 |
699 |
0.7 |
chr6_84139999_84140706 | 5.42 |
ME1 |
malic enzyme 1, NADP(+)-dependent, cytosolic |
412 |
0.89 |
chr21_46825103_46825740 | 5.41 |
COL18A1 |
collagen, type XVIII, alpha 1 |
369 |
0.83 |
chr1_205648469_205649627 | 5.40 |
SLC45A3 |
solute carrier family 45, member 3 |
539 |
0.74 |
chr22_25348691_25349626 | 5.40 |
KIAA1671 |
KIAA1671 |
461 |
0.83 |
chr20_9048816_9049419 | 5.39 |
PLCB4 |
phospholipase C, beta 4 |
293 |
0.9 |
chr15_65066905_65067558 | 5.33 |
RBPMS2 |
RNA binding protein with multiple splicing 2 |
555 |
0.69 |
chr20_55204347_55205219 | 5.32 |
TFAP2C |
transcription factor AP-2 gamma (activating enhancer binding protein 2 gamma) |
425 |
0.81 |
chr11_94473290_94474384 | 5.30 |
RP11-867G2.8 |
|
316 |
0.92 |
chr3_24562978_24563646 | 5.28 |
ENSG00000265028 |
. |
386 |
0.87 |
chr2_112897330_112897707 | 5.28 |
FBLN7 |
fibulin 7 |
1358 |
0.52 |
chr21_46825742_46826418 | 5.28 |
COL18A1 |
collagen, type XVIII, alpha 1 |
1028 |
0.47 |
chr21_42539308_42539931 | 5.25 |
BACE2 |
beta-site APP-cleaving enzyme 2 |
109 |
0.53 |
chr4_146403033_146403938 | 5.24 |
SMAD1 |
SMAD family member 1 |
153 |
0.96 |
chr9_1051774_1052480 | 5.21 |
DMRT2 |
doublesex and mab-3 related transcription factor 2 |
513 |
0.84 |
chr22_45898941_45899504 | 5.21 |
FBLN1 |
fibulin 1 |
296 |
0.92 |
chrX_138774003_138774873 | 5.21 |
MCF2 |
MCF.2 cell line derived transforming sequence |
123 |
0.97 |
chr21_38071900_38072434 | 5.21 |
SIM2 |
single-minded family bHLH transcription factor 2 |
176 |
0.94 |
chr6_142622323_142623463 | 5.20 |
GPR126 |
G protein-coupled receptor 126 |
98 |
0.98 |
chr22_29702254_29703430 | 5.20 |
GAS2L1 |
growth arrest-specific 2 like 1 |
171 |
0.91 |
chr16_1664599_1665551 | 5.19 |
CRAMP1L |
Crm, cramped-like (Drosophila) |
434 |
0.69 |
chr8_49782515_49783288 | 5.19 |
SNAI2 |
snail family zinc finger 2 |
51087 |
0.18 |
chr7_37960238_37961117 | 5.18 |
EPDR1 |
ependymin related 1 |
245 |
0.94 |
chr2_176994908_176995460 | 5.18 |
HOXD8 |
homeobox D8 |
99 |
0.91 |
chr16_54319557_54319894 | 5.17 |
IRX3 |
iroquois homeobox 3 |
42 |
0.98 |
chr6_46458824_46459774 | 5.16 |
RCAN2 |
regulator of calcineurin 2 |
200 |
0.78 |
chr8_494526_494820 | 5.16 |
TDRP |
testis development related protein |
164 |
0.97 |
chr7_55087572_55088165 | 5.15 |
EGFR |
epidermal growth factor receptor |
1057 |
0.68 |
chr17_79373625_79374766 | 5.15 |
ENSG00000266392 |
. |
383 |
0.6 |
chr19_33685813_33686340 | 5.15 |
LRP3 |
low density lipoprotein receptor-related protein 3 |
586 |
0.65 |
chr7_1709889_1710442 | 5.14 |
ELFN1 |
extracellular leucine-rich repeat and fibronectin type III domain containing 1 |
17590 |
0.18 |
chr19_1315736_1316102 | 5.14 |
EFNA2 |
ephrin-A2 |
29766 |
0.07 |
chr16_67282110_67283381 | 5.14 |
SLC9A5 |
solute carrier family 9, subfamily A (NHE5, cation proton antiporter 5), member 5 |
108 |
0.89 |
chr9_34651822_34652525 | 5.13 |
IL11RA |
interleukin 11 receptor, alpha |
16 |
0.94 |
chr5_83017716_83018280 | 5.12 |
HAPLN1 |
hyaluronan and proteoglycan link protein 1 |
566 |
0.78 |
chr2_29338259_29338523 | 5.09 |
CLIP4 |
CAP-GLY domain containing linker protein family, member 4 |
99 |
0.96 |
chr19_4064037_4064881 | 5.09 |
ZBTB7A |
zinc finger and BTB domain containing 7A |
1271 |
0.28 |
chr18_35146776_35147412 | 5.08 |
CELF4 |
CUGBP, Elav-like family member 4 |
1094 |
0.67 |
chr10_88159807_88161210 | 5.08 |
GRID1 |
glutamate receptor, ionotropic, delta 1 |
34273 |
0.17 |
chr2_11622794_11623343 | 5.08 |
E2F6 |
E2F transcription factor 6 |
16793 |
0.13 |
chr20_6032553_6033205 | 5.07 |
LRRN4 |
leucine rich repeat neuronal 4 |
1816 |
0.35 |
chr5_131562588_131563831 | 5.07 |
P4HA2 |
prolyl 4-hydroxylase, alpha polypeptide II |
138 |
0.96 |
chrX_9754461_9754895 | 5.06 |
SHROOM2 |
shroom family member 2 |
182 |
0.69 |
chr3_96531977_96533205 | 5.04 |
EPHA6 |
EPH receptor A6 |
834 |
0.76 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
8.6 | 25.8 | GO:0060083 | smooth muscle contraction involved in micturition(GO:0060083) |
6.6 | 19.8 | GO:0061364 | apoptotic process involved in luteolysis(GO:0061364) |
6.6 | 13.2 | GO:0060677 | ureteric bud elongation(GO:0060677) |
5.9 | 17.6 | GO:0002072 | optic cup morphogenesis involved in camera-type eye development(GO:0002072) |
5.5 | 16.4 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
5.4 | 16.2 | GO:1900115 | sequestering of extracellular ligand from receptor(GO:0035581) sequestering of TGFbeta in extracellular matrix(GO:0035583) protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) extracellular regulation of signal transduction(GO:1900115) extracellular negative regulation of signal transduction(GO:1900116) |
5.2 | 15.5 | GO:0072081 | proximal/distal pattern formation involved in nephron development(GO:0072047) specification of nephron tubule identity(GO:0072081) |
4.8 | 14.5 | GO:0033087 | negative regulation of immature T cell proliferation(GO:0033087) negative regulation of immature T cell proliferation in thymus(GO:0033088) |
4.5 | 13.5 | GO:0021508 | floor plate formation(GO:0021508) |
4.5 | 4.5 | GO:0060594 | mammary gland specification(GO:0060594) |
4.4 | 13.2 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
4.3 | 17.4 | GO:0060737 | prostate gland morphogenetic growth(GO:0060737) |
4.3 | 8.6 | GO:0060684 | epithelial-mesenchymal cell signaling(GO:0060684) |
4.3 | 17.0 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
4.2 | 12.5 | GO:0051451 | myoblast migration(GO:0051451) |
4.0 | 11.9 | GO:0015803 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
3.9 | 3.9 | GO:0061004 | pattern specification involved in kidney development(GO:0061004) renal system pattern specification(GO:0072048) pattern specification involved in metanephros development(GO:0072268) |
3.7 | 7.5 | GO:0007500 | mesodermal cell fate determination(GO:0007500) |
3.7 | 3.7 | GO:0051898 | negative regulation of protein kinase B signaling(GO:0051898) |
3.7 | 14.7 | GO:0070141 | response to UV-A(GO:0070141) |
3.6 | 10.9 | GO:0055098 | response to low-density lipoprotein particle(GO:0055098) |
3.5 | 3.5 | GO:0050923 | regulation of negative chemotaxis(GO:0050923) |
3.5 | 17.3 | GO:0003321 | positive regulation of blood pressure by epinephrine-norepinephrine(GO:0003321) |
3.4 | 6.9 | GO:0060129 | thyroid-stimulating hormone-secreting cell differentiation(GO:0060129) |
3.4 | 10.2 | GO:0046322 | negative regulation of fatty acid oxidation(GO:0046322) |
3.4 | 3.4 | GO:0072179 | nephric duct formation(GO:0072179) |
3.4 | 13.4 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
3.3 | 6.6 | GO:0060748 | tertiary branching involved in mammary gland duct morphogenesis(GO:0060748) |
3.3 | 9.8 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
3.2 | 6.4 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
3.1 | 3.1 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) |
3.0 | 6.1 | GO:0060839 | endothelial cell fate commitment(GO:0060839) |
3.0 | 9.1 | GO:0032344 | regulation of ketone biosynthetic process(GO:0010566) regulation of aldosterone metabolic process(GO:0032344) regulation of aldosterone biosynthetic process(GO:0032347) |
2.9 | 8.8 | GO:0032808 | lacrimal gland development(GO:0032808) |
2.9 | 2.9 | GO:0070933 | histone H3 deacetylation(GO:0070932) histone H4 deacetylation(GO:0070933) |
2.8 | 11.2 | GO:1901889 | negative regulation of focal adhesion assembly(GO:0051895) negative regulation of cell junction assembly(GO:1901889) negative regulation of adherens junction organization(GO:1903392) |
2.8 | 14.0 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
2.8 | 5.5 | GO:0071502 | cellular response to temperature stimulus(GO:0071502) |
2.8 | 5.5 | GO:0010159 | specification of organ position(GO:0010159) |
2.8 | 11.0 | GO:0071364 | cellular response to epidermal growth factor stimulus(GO:0071364) |
2.7 | 5.5 | GO:0072070 | loop of Henle development(GO:0072070) |
2.7 | 5.4 | GO:0021563 | glossopharyngeal nerve development(GO:0021563) glossopharyngeal nerve morphogenesis(GO:0021615) |
2.7 | 8.1 | GO:0061072 | iris morphogenesis(GO:0061072) |
2.7 | 8.1 | GO:0010842 | retina layer formation(GO:0010842) |
2.6 | 5.3 | GO:0033603 | positive regulation of dopamine secretion(GO:0033603) |
2.6 | 7.8 | GO:0048319 | axial mesoderm morphogenesis(GO:0048319) |
2.5 | 5.1 | GO:0060059 | embryonic retina morphogenesis in camera-type eye(GO:0060059) |
2.5 | 7.5 | GO:0021932 | hindbrain radial glia guided cell migration(GO:0021932) |
2.5 | 2.5 | GO:0000098 | sulfur amino acid catabolic process(GO:0000098) |
2.5 | 2.5 | GO:0003171 | atrioventricular valve development(GO:0003171) atrioventricular valve morphogenesis(GO:0003181) |
2.4 | 2.4 | GO:0060430 | lung saccule development(GO:0060430) Type II pneumocyte differentiation(GO:0060510) |
2.4 | 7.2 | GO:0060028 | convergent extension involved in axis elongation(GO:0060028) |
2.4 | 16.8 | GO:0021952 | central nervous system projection neuron axonogenesis(GO:0021952) |
2.4 | 2.4 | GO:0022601 | menstrual cycle phase(GO:0022601) |
2.3 | 9.2 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
2.3 | 6.9 | GO:0043129 | surfactant homeostasis(GO:0043129) chemical homeostasis within a tissue(GO:0048875) |
2.3 | 2.3 | GO:0060685 | regulation of prostatic bud formation(GO:0060685) |
2.3 | 4.6 | GO:0060438 | trachea development(GO:0060438) |
2.3 | 15.8 | GO:0007185 | transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
2.3 | 2.3 | GO:0003308 | negative regulation of Wnt signaling pathway involved in heart development(GO:0003308) |
2.2 | 2.2 | GO:0045636 | regulation of melanocyte differentiation(GO:0045634) positive regulation of melanocyte differentiation(GO:0045636) regulation of pigment cell differentiation(GO:0050932) positive regulation of pigment cell differentiation(GO:0050942) |
2.2 | 2.2 | GO:0045992 | negative regulation of embryonic development(GO:0045992) |
2.2 | 2.2 | GO:0060592 | mammary gland formation(GO:0060592) |
2.2 | 8.7 | GO:0060013 | righting reflex(GO:0060013) |
2.2 | 8.7 | GO:0097531 | mast cell chemotaxis(GO:0002551) regulation of mast cell chemotaxis(GO:0060753) positive regulation of mast cell chemotaxis(GO:0060754) mast cell migration(GO:0097531) |
2.2 | 8.6 | GO:0010665 | striated muscle cell apoptotic process(GO:0010658) cardiac muscle cell apoptotic process(GO:0010659) regulation of striated muscle cell apoptotic process(GO:0010662) negative regulation of striated muscle cell apoptotic process(GO:0010664) regulation of cardiac muscle cell apoptotic process(GO:0010665) negative regulation of cardiac muscle cell apoptotic process(GO:0010667) |
2.1 | 10.6 | GO:0042983 | amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
2.1 | 4.2 | GO:0060534 | trachea cartilage development(GO:0060534) trachea cartilage morphogenesis(GO:0060535) cartilage morphogenesis(GO:0060536) |
2.1 | 4.2 | GO:0007028 | cytoplasm organization(GO:0007028) |
2.1 | 6.3 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
2.1 | 4.1 | GO:0010757 | negative regulation of plasminogen activation(GO:0010757) |
2.0 | 10.2 | GO:0001946 | lymphangiogenesis(GO:0001946) lymph vessel morphogenesis(GO:0036303) |
2.0 | 6.1 | GO:0019511 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) 4-hydroxyproline metabolic process(GO:0019471) peptidyl-proline hydroxylation(GO:0019511) |
2.0 | 15.9 | GO:0045663 | positive regulation of myoblast differentiation(GO:0045663) |
2.0 | 2.0 | GO:0032351 | negative regulation of hormone metabolic process(GO:0032351) negative regulation of hormone biosynthetic process(GO:0032353) |
2.0 | 5.9 | GO:0016115 | diterpenoid catabolic process(GO:0016103) terpenoid catabolic process(GO:0016115) retinoic acid catabolic process(GO:0034653) |
1.9 | 1.9 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
1.9 | 7.7 | GO:0010955 | negative regulation of protein processing(GO:0010955) negative regulation of protein maturation(GO:1903318) |
1.9 | 1.9 | GO:0006295 | nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) |
1.9 | 1.9 | GO:1901881 | positive regulation of protein depolymerization(GO:1901881) |
1.9 | 19.0 | GO:0034446 | substrate adhesion-dependent cell spreading(GO:0034446) |
1.9 | 3.8 | GO:0048485 | sympathetic nervous system development(GO:0048485) |
1.9 | 7.5 | GO:0070208 | protein heterotrimerization(GO:0070208) |
1.8 | 7.4 | GO:0008218 | bioluminescence(GO:0008218) |
1.8 | 1.8 | GO:0042637 | catagen(GO:0042637) |
1.8 | 14.5 | GO:0055093 | response to increased oxygen levels(GO:0036296) response to hyperoxia(GO:0055093) |
1.8 | 5.4 | GO:0060573 | ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
1.8 | 3.6 | GO:0032331 | negative regulation of chondrocyte differentiation(GO:0032331) |
1.8 | 10.6 | GO:0016264 | gap junction assembly(GO:0016264) |
1.7 | 5.2 | GO:0034201 | response to oleic acid(GO:0034201) |
1.7 | 1.7 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
1.7 | 6.9 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
1.7 | 5.1 | GO:0071875 | adrenergic receptor signaling pathway(GO:0071875) activation of MAPK activity by adrenergic receptor signaling pathway(GO:0071883) |
1.7 | 3.4 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
1.7 | 5.1 | GO:0009648 | photoperiodism(GO:0009648) |
1.7 | 3.3 | GO:0048702 | embryonic neurocranium morphogenesis(GO:0048702) |
1.7 | 9.9 | GO:0031272 | pseudopodium assembly(GO:0031269) regulation of pseudopodium assembly(GO:0031272) positive regulation of pseudopodium assembly(GO:0031274) |
1.7 | 5.0 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
1.6 | 4.9 | GO:0009756 | carbohydrate mediated signaling(GO:0009756) |
1.6 | 6.6 | GO:0051541 | elastin metabolic process(GO:0051541) |
1.6 | 9.9 | GO:1904893 | negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
1.6 | 9.9 | GO:0031641 | regulation of myelination(GO:0031641) |
1.6 | 4.9 | GO:0018243 | protein O-linked glycosylation via serine(GO:0018242) protein O-linked glycosylation via threonine(GO:0018243) |
1.6 | 3.3 | GO:0015868 | purine ribonucleotide transport(GO:0015868) |
1.6 | 3.2 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
1.6 | 4.9 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
1.6 | 9.7 | GO:0008595 | tripartite regional subdivision(GO:0007351) anterior/posterior axis specification, embryo(GO:0008595) |
1.6 | 4.8 | GO:0050807 | regulation of synapse organization(GO:0050807) |
1.6 | 20.8 | GO:0035329 | hippo signaling(GO:0035329) |
1.6 | 3.2 | GO:1903579 | negative regulation of nucleoside metabolic process(GO:0045978) negative regulation of ATP metabolic process(GO:1903579) |
1.6 | 4.8 | GO:0051305 | chromosome movement towards spindle pole(GO:0051305) |
1.6 | 7.9 | GO:0048715 | negative regulation of oligodendrocyte differentiation(GO:0048715) |
1.6 | 4.8 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) platelet activating factor metabolic process(GO:0046469) |
1.6 | 3.2 | GO:0043113 | receptor clustering(GO:0043113) |
1.6 | 1.6 | GO:0060259 | regulation of feeding behavior(GO:0060259) |
1.6 | 4.7 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
1.5 | 7.7 | GO:0048013 | ephrin receptor signaling pathway(GO:0048013) |
1.5 | 9.2 | GO:0055003 | cardiac myofibril assembly(GO:0055003) |
1.5 | 7.6 | GO:0090083 | regulation of inclusion body assembly(GO:0090083) |
1.5 | 4.6 | GO:0021542 | dentate gyrus development(GO:0021542) |
1.5 | 3.0 | GO:0001880 | Mullerian duct regression(GO:0001880) |
1.5 | 3.0 | GO:0003078 | obsolete regulation of natriuresis(GO:0003078) |
1.5 | 5.9 | GO:0048048 | embryonic eye morphogenesis(GO:0048048) |
1.5 | 17.6 | GO:0006893 | Golgi to plasma membrane transport(GO:0006893) vesicle-mediated transport to the plasma membrane(GO:0098876) |
1.5 | 5.8 | GO:0014824 | tonic smooth muscle contraction(GO:0014820) artery smooth muscle contraction(GO:0014824) |
1.5 | 4.4 | GO:0022605 | oogenesis stage(GO:0022605) |
1.4 | 4.3 | GO:0045112 | integrin biosynthetic process(GO:0045112) |
1.4 | 26.0 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
1.4 | 1.4 | GO:0060214 | endocardium formation(GO:0060214) |
1.4 | 1.4 | GO:0007207 | phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
1.4 | 4.3 | GO:0021555 | midbrain-hindbrain boundary morphogenesis(GO:0021555) |
1.4 | 1.4 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
1.4 | 4.3 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
1.4 | 4.3 | GO:0071392 | cellular response to estradiol stimulus(GO:0071392) |
1.4 | 1.4 | GO:0021904 | dorsal/ventral neural tube patterning(GO:0021904) |
1.4 | 2.8 | GO:0050773 | regulation of dendrite development(GO:0050773) |
1.4 | 7.0 | GO:0060363 | cranial suture morphogenesis(GO:0060363) craniofacial suture morphogenesis(GO:0097094) |
1.4 | 6.9 | GO:0042219 | cellular modified amino acid catabolic process(GO:0042219) |
1.4 | 2.8 | GO:0045617 | negative regulation of keratinocyte differentiation(GO:0045617) |
1.4 | 5.5 | GO:0032455 | nerve growth factor processing(GO:0032455) |
1.4 | 5.5 | GO:0061029 | eyelid development in camera-type eye(GO:0061029) |
1.4 | 4.1 | GO:0070092 | regulation of glucagon secretion(GO:0070092) |
1.4 | 2.7 | GO:0048865 | stem cell fate commitment(GO:0048865) stem cell fate determination(GO:0048867) |
1.4 | 1.4 | GO:0010837 | regulation of keratinocyte proliferation(GO:0010837) |
1.4 | 8.2 | GO:0015871 | choline transport(GO:0015871) |
1.3 | 2.7 | GO:0043552 | positive regulation of phosphatidylinositol 3-kinase activity(GO:0043552) |
1.3 | 2.7 | GO:0010700 | negative regulation of norepinephrine secretion(GO:0010700) |
1.3 | 1.3 | GO:0061299 | retina vasculature development in camera-type eye(GO:0061298) retina vasculature morphogenesis in camera-type eye(GO:0061299) |
1.3 | 8.0 | GO:0021895 | cerebral cortex neuron differentiation(GO:0021895) |
1.3 | 18.6 | GO:0007528 | neuromuscular junction development(GO:0007528) |
1.3 | 9.2 | GO:0006198 | cAMP catabolic process(GO:0006198) |
1.3 | 1.3 | GO:0060437 | lung growth(GO:0060437) |
1.3 | 3.9 | GO:0046549 | retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) camera-type eye photoreceptor cell differentiation(GO:0060219) |
1.3 | 2.6 | GO:0060453 | regulation of gastric acid secretion(GO:0060453) |
1.3 | 2.6 | GO:2000178 | negative regulation of neuroblast proliferation(GO:0007406) negative regulation of neural precursor cell proliferation(GO:2000178) |
1.3 | 3.8 | GO:0045880 | positive regulation of smoothened signaling pathway(GO:0045880) |
1.3 | 2.5 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
1.3 | 6.3 | GO:0003214 | cardiac left ventricle morphogenesis(GO:0003214) |
1.3 | 2.5 | GO:0051497 | negative regulation of stress fiber assembly(GO:0051497) |
1.3 | 2.5 | GO:0030422 | production of siRNA involved in RNA interference(GO:0030422) |
1.3 | 10.1 | GO:0099518 | vesicle transport along microtubule(GO:0047496) vesicle cytoskeletal trafficking(GO:0099518) |
1.2 | 1.2 | GO:0002246 | wound healing involved in inflammatory response(GO:0002246) inflammatory response to wounding(GO:0090594) |
1.2 | 9.9 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
1.2 | 8.6 | GO:0021781 | glial cell fate commitment(GO:0021781) |
1.2 | 3.7 | GO:0070874 | negative regulation of glycogen metabolic process(GO:0070874) |
1.2 | 1.2 | GO:0046958 | nonassociative learning(GO:0046958) |
1.2 | 3.6 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
1.2 | 18.2 | GO:0030199 | collagen fibril organization(GO:0030199) |
1.2 | 2.4 | GO:0032236 | obsolete positive regulation of calcium ion transport via store-operated calcium channel activity(GO:0032236) |
1.2 | 2.4 | GO:0010882 | regulation of cardiac muscle contraction by calcium ion signaling(GO:0010882) |
1.2 | 2.4 | GO:0040037 | negative regulation of fibroblast growth factor receptor signaling pathway(GO:0040037) |
1.2 | 9.4 | GO:0042474 | middle ear morphogenesis(GO:0042474) |
1.2 | 3.5 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
1.2 | 1.2 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
1.2 | 8.2 | GO:0009404 | toxin metabolic process(GO:0009404) |
1.2 | 7.0 | GO:0032233 | positive regulation of actin filament bundle assembly(GO:0032233) |
1.2 | 3.5 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
1.2 | 3.5 | GO:0048738 | cardiac muscle tissue development(GO:0048738) |
1.1 | 4.5 | GO:0006991 | response to sterol depletion(GO:0006991) |
1.1 | 2.3 | GO:0003310 | pancreatic A cell differentiation(GO:0003310) |
1.1 | 3.3 | GO:0032288 | myelin assembly(GO:0032288) |
1.1 | 1.1 | GO:0021854 | hypothalamus development(GO:0021854) |
1.1 | 17.6 | GO:0008038 | neuron recognition(GO:0008038) |
1.1 | 4.4 | GO:0019367 | fatty acid elongation, saturated fatty acid(GO:0019367) |
1.1 | 2.2 | GO:0030241 | skeletal muscle myosin thick filament assembly(GO:0030241) myosin filament assembly(GO:0031034) striated muscle myosin thick filament assembly(GO:0071688) |
1.1 | 1.1 | GO:0046083 | adenine salvage(GO:0006168) purine nucleobase salvage(GO:0043096) adenine metabolic process(GO:0046083) adenine biosynthetic process(GO:0046084) |
1.1 | 4.3 | GO:0051602 | response to electrical stimulus(GO:0051602) |
1.1 | 1.1 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
1.1 | 4.3 | GO:0048333 | mesodermal cell differentiation(GO:0048333) |
1.1 | 3.2 | GO:0061726 | mitophagy(GO:0000422) mitochondrion disassembly(GO:0061726) |
1.1 | 4.2 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
1.1 | 6.4 | GO:0006477 | protein sulfation(GO:0006477) |
1.1 | 1.1 | GO:0033079 | immature T cell proliferation(GO:0033079) |
1.0 | 6.3 | GO:0042249 | establishment of planar polarity of embryonic epithelium(GO:0042249) |
1.0 | 1.0 | GO:0018126 | protein hydroxylation(GO:0018126) |
1.0 | 8.3 | GO:0006108 | malate metabolic process(GO:0006108) |
1.0 | 5.2 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
1.0 | 2.1 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
1.0 | 1.0 | GO:0003161 | cardiac conduction system development(GO:0003161) |
1.0 | 4.1 | GO:0001757 | somite specification(GO:0001757) |
1.0 | 2.0 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
1.0 | 2.0 | GO:0021800 | cerebral cortex tangential migration(GO:0021800) |
1.0 | 6.1 | GO:0007199 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger(GO:0007199) |
1.0 | 6.1 | GO:0060314 | regulation of ryanodine-sensitive calcium-release channel activity(GO:0060314) |
1.0 | 1.0 | GO:0043114 | regulation of vascular permeability(GO:0043114) |
1.0 | 3.0 | GO:0071398 | cellular response to fatty acid(GO:0071398) |
1.0 | 3.0 | GO:0021517 | ventral spinal cord development(GO:0021517) |
1.0 | 6.9 | GO:0007274 | neuromuscular synaptic transmission(GO:0007274) |
1.0 | 2.0 | GO:0050703 | interleukin-1 alpha secretion(GO:0050703) |
1.0 | 3.0 | GO:0048293 | isotype switching to IgE isotypes(GO:0048289) regulation of isotype switching to IgE isotypes(GO:0048293) |
1.0 | 2.0 | GO:0033630 | positive regulation of cell adhesion mediated by integrin(GO:0033630) |
1.0 | 2.9 | GO:0098868 | endochondral bone growth(GO:0003416) growth plate cartilage development(GO:0003417) bone growth(GO:0098868) |
1.0 | 4.9 | GO:0002076 | osteoblast development(GO:0002076) |
1.0 | 2.0 | GO:0048799 | organ maturation(GO:0048799) bone maturation(GO:0070977) |
1.0 | 2.9 | GO:0021873 | forebrain neuroblast division(GO:0021873) |
1.0 | 6.7 | GO:0010324 | phagocytosis, engulfment(GO:0006911) membrane invagination(GO:0010324) |
1.0 | 3.8 | GO:0090025 | regulation of monocyte chemotaxis(GO:0090025) positive regulation of monocyte chemotaxis(GO:0090026) |
0.9 | 3.8 | GO:0032227 | negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
0.9 | 1.9 | GO:0016999 | antibiotic metabolic process(GO:0016999) antibiotic biosynthetic process(GO:0017000) |
0.9 | 0.9 | GO:1905145 | G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) acetylcholine receptor signaling pathway(GO:0095500) postsynaptic signal transduction(GO:0098926) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
0.9 | 0.9 | GO:0045964 | positive regulation of catecholamine metabolic process(GO:0045915) positive regulation of dopamine metabolic process(GO:0045964) |
0.9 | 2.8 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.9 | 0.9 | GO:0045077 | negative regulation of interferon-gamma biosynthetic process(GO:0045077) |
0.9 | 3.7 | GO:0090102 | cochlea development(GO:0090102) |
0.9 | 1.9 | GO:1901985 | positive regulation of histone acetylation(GO:0035066) positive regulation of protein acetylation(GO:1901985) positive regulation of peptidyl-lysine acetylation(GO:2000758) |
0.9 | 4.6 | GO:0046337 | phosphatidylethanolamine biosynthetic process(GO:0006646) phosphatidylethanolamine metabolic process(GO:0046337) |
0.9 | 1.9 | GO:0060267 | positive regulation of respiratory burst(GO:0060267) |
0.9 | 8.3 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
0.9 | 0.9 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
0.9 | 3.6 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.9 | 2.7 | GO:0045875 | negative regulation of sister chromatid cohesion(GO:0045875) |
0.9 | 5.4 | GO:0034331 | cell junction maintenance(GO:0034331) cell-cell junction maintenance(GO:0045217) |
0.9 | 2.7 | GO:0043306 | positive regulation of mast cell activation involved in immune response(GO:0033008) positive regulation of leukocyte degranulation(GO:0043302) positive regulation of mast cell degranulation(GO:0043306) |
0.9 | 4.4 | GO:0050435 | beta-amyloid metabolic process(GO:0050435) |
0.9 | 2.6 | GO:0051798 | positive regulation of hair cycle(GO:0042635) positive regulation of hair follicle development(GO:0051798) |
0.9 | 5.3 | GO:0016540 | protein autoprocessing(GO:0016540) |
0.9 | 0.9 | GO:0043281 | regulation of cysteine-type endopeptidase activity involved in apoptotic process(GO:0043281) |
0.9 | 9.7 | GO:0007263 | nitric oxide mediated signal transduction(GO:0007263) |
0.9 | 1.8 | GO:0031622 | regulation of fever generation(GO:0031620) positive regulation of fever generation(GO:0031622) |
0.9 | 7.0 | GO:0015732 | prostaglandin transport(GO:0015732) |
0.9 | 5.2 | GO:0040020 | regulation of meiotic nuclear division(GO:0040020) |
0.9 | 2.6 | GO:0008215 | spermine metabolic process(GO:0008215) |
0.9 | 4.3 | GO:0050919 | negative chemotaxis(GO:0050919) |
0.9 | 2.6 | GO:0070779 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
0.9 | 5.1 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.9 | 0.9 | GO:0021591 | ventricular system development(GO:0021591) |
0.9 | 0.9 | GO:0048934 | peripheral nervous system neuron differentiation(GO:0048934) |
0.9 | 0.9 | GO:0021889 | olfactory bulb interneuron differentiation(GO:0021889) |
0.8 | 11.9 | GO:0030865 | cortical cytoskeleton organization(GO:0030865) |
0.8 | 4.2 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
0.8 | 2.5 | GO:0071425 | hematopoietic stem cell proliferation(GO:0071425) |
0.8 | 3.4 | GO:0021571 | rhombomere 5 development(GO:0021571) |
0.8 | 3.4 | GO:0048009 | insulin-like growth factor receptor signaling pathway(GO:0048009) |
0.8 | 5.0 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.8 | 1.7 | GO:0006106 | fumarate metabolic process(GO:0006106) |
0.8 | 3.3 | GO:0071445 | obsolete cellular response to protein stimulus(GO:0071445) |
0.8 | 2.5 | GO:0050432 | catecholamine secretion(GO:0050432) |
0.8 | 2.5 | GO:0015864 | pyrimidine nucleoside transport(GO:0015864) |
0.8 | 3.3 | GO:0015802 | basic amino acid transport(GO:0015802) |
0.8 | 4.1 | GO:0002675 | positive regulation of acute inflammatory response(GO:0002675) |
0.8 | 6.5 | GO:0007530 | sex determination(GO:0007530) |
0.8 | 7.3 | GO:0009650 | UV protection(GO:0009650) |
0.8 | 2.4 | GO:0051956 | negative regulation of amino acid transport(GO:0051956) |
0.8 | 2.4 | GO:0002283 | neutrophil activation involved in immune response(GO:0002283) neutrophil degranulation(GO:0043312) |
0.8 | 9.7 | GO:0007215 | glutamate receptor signaling pathway(GO:0007215) |
0.8 | 0.8 | GO:0071731 | response to nitric oxide(GO:0071731) |
0.8 | 1.6 | GO:0061318 | renal filtration cell differentiation(GO:0061318) glomerular epithelium development(GO:0072010) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
0.8 | 1.6 | GO:0048566 | embryonic digestive tract development(GO:0048566) |
0.8 | 2.4 | GO:0051482 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway(GO:0051482) |
0.8 | 8.6 | GO:0006688 | glycosphingolipid biosynthetic process(GO:0006688) |
0.8 | 0.8 | GO:0060435 | bronchiole development(GO:0060435) |
0.8 | 0.8 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.8 | 1.6 | GO:0048630 | skeletal muscle tissue growth(GO:0048630) |
0.8 | 0.8 | GO:1900120 | regulation of receptor binding(GO:1900120) negative regulation of receptor binding(GO:1900121) |
0.8 | 0.8 | GO:0060456 | positive regulation of digestive system process(GO:0060456) |
0.8 | 1.5 | GO:0010834 | obsolete telomere maintenance via telomere shortening(GO:0010834) |
0.8 | 21.3 | GO:0007193 | adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway(GO:0007193) |
0.8 | 2.3 | GO:0001958 | endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
0.8 | 1.5 | GO:0048820 | hair cycle phase(GO:0044851) hair follicle maturation(GO:0048820) |
0.8 | 7.5 | GO:0050766 | positive regulation of phagocytosis(GO:0050766) |
0.7 | 2.2 | GO:0014003 | oligodendrocyte development(GO:0014003) |
0.7 | 3.0 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.7 | 3.7 | GO:0008347 | glial cell migration(GO:0008347) |
0.7 | 6.6 | GO:0051017 | actin filament bundle assembly(GO:0051017) actin filament bundle organization(GO:0061572) |
0.7 | 2.2 | GO:0008614 | pyridoxine metabolic process(GO:0008614) pyridoxine biosynthetic process(GO:0008615) vitamin B6 metabolic process(GO:0042816) vitamin B6 biosynthetic process(GO:0042819) |
0.7 | 5.1 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
0.7 | 1.5 | GO:0007352 | zygotic specification of dorsal/ventral axis(GO:0007352) |
0.7 | 2.2 | GO:0033197 | response to vitamin E(GO:0033197) |
0.7 | 3.6 | GO:0006837 | serotonin transport(GO:0006837) |
0.7 | 13.8 | GO:0048489 | synaptic vesicle transport(GO:0048489) synaptic vesicle localization(GO:0097479) establishment of synaptic vesicle localization(GO:0097480) |
0.7 | 5.8 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.7 | 1.5 | GO:0050955 | thermoception(GO:0050955) |
0.7 | 3.6 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
0.7 | 2.2 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.7 | 4.3 | GO:0009629 | response to gravity(GO:0009629) |
0.7 | 12.2 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.7 | 10.1 | GO:0030815 | negative regulation of cAMP metabolic process(GO:0030815) negative regulation of cAMP biosynthetic process(GO:0030818) |
0.7 | 5.0 | GO:0030252 | growth hormone secretion(GO:0030252) |
0.7 | 4.3 | GO:0007616 | long-term memory(GO:0007616) |
0.7 | 2.1 | GO:0017121 | phospholipid scrambling(GO:0017121) |
0.7 | 5.0 | GO:0051927 | obsolete negative regulation of calcium ion transport via voltage-gated calcium channel activity(GO:0051927) |
0.7 | 0.7 | GO:0045715 | negative regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045715) |
0.7 | 2.8 | GO:0016266 | O-glycan processing(GO:0016266) |
0.7 | 3.5 | GO:0002281 | macrophage activation involved in immune response(GO:0002281) |
0.7 | 6.4 | GO:0048265 | response to pain(GO:0048265) |
0.7 | 8.5 | GO:0001893 | maternal placenta development(GO:0001893) |
0.7 | 3.5 | GO:1903963 | arachidonic acid secretion(GO:0050482) arachidonate transport(GO:1903963) |
0.7 | 7.7 | GO:0001709 | cell fate determination(GO:0001709) |
0.7 | 3.5 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
0.7 | 6.3 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.7 | 4.2 | GO:0032376 | positive regulation of sterol transport(GO:0032373) positive regulation of cholesterol transport(GO:0032376) |
0.7 | 2.8 | GO:0060009 | Sertoli cell development(GO:0060009) |
0.7 | 3.4 | GO:0045197 | establishment or maintenance of epithelial cell apical/basal polarity(GO:0045197) |
0.7 | 4.8 | GO:0021516 | dorsal spinal cord development(GO:0021516) |
0.7 | 2.1 | GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
0.7 | 2.7 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.7 | 5.4 | GO:0007184 | SMAD protein import into nucleus(GO:0007184) |
0.7 | 0.7 | GO:0021910 | smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021910) |
0.7 | 8.8 | GO:0014823 | response to activity(GO:0014823) |
0.7 | 5.4 | GO:0051654 | establishment of mitochondrion localization(GO:0051654) |
0.7 | 4.1 | GO:0034260 | negative regulation of GTPase activity(GO:0034260) |
0.7 | 0.7 | GO:0055057 | neuronal stem cell division(GO:0036445) neuroblast division(GO:0055057) |
0.7 | 10.7 | GO:0045103 | intermediate filament-based process(GO:0045103) |
0.7 | 2.0 | GO:0070528 | protein kinase C signaling(GO:0070528) |
0.7 | 1.3 | GO:0002407 | dendritic cell chemotaxis(GO:0002407) dendritic cell migration(GO:0036336) |
0.7 | 0.7 | GO:0045603 | positive regulation of endothelial cell differentiation(GO:0045603) |
0.7 | 4.0 | GO:0010862 | positive regulation of pathway-restricted SMAD protein phosphorylation(GO:0010862) |
0.7 | 2.7 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
0.7 | 10.0 | GO:0006940 | regulation of smooth muscle contraction(GO:0006940) |
0.7 | 2.0 | GO:0034214 | protein hexamerization(GO:0034214) |
0.7 | 3.3 | GO:0001960 | negative regulation of cytokine-mediated signaling pathway(GO:0001960) |
0.7 | 2.0 | GO:0030091 | protein repair(GO:0030091) |
0.7 | 9.2 | GO:0070374 | positive regulation of ERK1 and ERK2 cascade(GO:0070374) |
0.7 | 46.5 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
0.7 | 9.1 | GO:0048010 | vascular endothelial growth factor receptor signaling pathway(GO:0048010) |
0.6 | 7.1 | GO:0017158 | regulation of calcium ion-dependent exocytosis(GO:0017158) |
0.6 | 1.3 | GO:0060527 | prostate glandular acinus morphogenesis(GO:0060526) prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis(GO:0060527) |
0.6 | 0.6 | GO:1901374 | acetylcholine transport(GO:0015870) acetate ester transport(GO:1901374) |
0.6 | 1.3 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.6 | 0.6 | GO:0060008 | Sertoli cell differentiation(GO:0060008) |
0.6 | 3.1 | GO:0007549 | dosage compensation(GO:0007549) |
0.6 | 1.9 | GO:0006657 | CDP-choline pathway(GO:0006657) |
0.6 | 7.5 | GO:0007613 | memory(GO:0007613) |
0.6 | 4.9 | GO:0015671 | oxygen transport(GO:0015671) |
0.6 | 1.8 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.6 | 0.6 | GO:0042538 | hyperosmotic salinity response(GO:0042538) |
0.6 | 8.5 | GO:0035195 | gene silencing by miRNA(GO:0035195) |
0.6 | 1.2 | GO:0051788 | response to misfolded protein(GO:0051788) |
0.6 | 1.2 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.6 | 4.2 | GO:0006884 | cell volume homeostasis(GO:0006884) |
0.6 | 3.0 | GO:0043277 | apoptotic cell clearance(GO:0043277) |
0.6 | 9.6 | GO:0006182 | cGMP biosynthetic process(GO:0006182) |
0.6 | 2.4 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.6 | 1.2 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
0.6 | 3.0 | GO:0046541 | saliva secretion(GO:0046541) |
0.6 | 1.2 | GO:0060039 | pericardium development(GO:0060039) |
0.6 | 13.0 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.6 | 1.2 | GO:0048625 | myoblast fate commitment(GO:0048625) |
0.6 | 0.6 | GO:0071548 | response to dexamethasone(GO:0071548) |
0.6 | 0.6 | GO:2000647 | negative regulation of stem cell proliferation(GO:2000647) |
0.6 | 4.1 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.6 | 0.6 | GO:0048755 | branching morphogenesis of a nerve(GO:0048755) |
0.6 | 1.7 | GO:0008354 | germ cell migration(GO:0008354) |
0.6 | 0.6 | GO:0014819 | regulation of skeletal muscle contraction(GO:0014819) |
0.6 | 2.3 | GO:0007622 | rhythmic behavior(GO:0007622) |
0.6 | 0.6 | GO:0060174 | limb bud formation(GO:0060174) |
0.6 | 0.6 | GO:0009111 | vitamin catabolic process(GO:0009111) fat-soluble vitamin catabolic process(GO:0042363) |
0.6 | 1.1 | GO:0061384 | heart trabecula formation(GO:0060347) heart trabecula morphogenesis(GO:0061384) |
0.6 | 2.8 | GO:0030325 | adrenal gland development(GO:0030325) |
0.6 | 1.7 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
0.6 | 68.3 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.6 | 1.1 | GO:0006591 | ornithine metabolic process(GO:0006591) |
0.6 | 3.4 | GO:0048663 | neuron fate commitment(GO:0048663) |
0.6 | 3.4 | GO:0072163 | ureteric bud development(GO:0001657) mesonephric epithelium development(GO:0072163) mesonephric tubule development(GO:0072164) |
0.6 | 8.9 | GO:0001764 | neuron migration(GO:0001764) |
0.6 | 23.4 | GO:0031424 | keratinization(GO:0031424) |
0.6 | 0.6 | GO:0009214 | cyclic nucleotide catabolic process(GO:0009214) |
0.5 | 1.6 | GO:0032098 | regulation of appetite(GO:0032098) |
0.5 | 0.5 | GO:0031650 | regulation of heat generation(GO:0031650) positive regulation of heat generation(GO:0031652) |
0.5 | 2.2 | GO:0051973 | positive regulation of telomerase activity(GO:0051973) |
0.5 | 1.6 | GO:0042339 | keratan sulfate metabolic process(GO:0042339) |
0.5 | 1.1 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
0.5 | 1.6 | GO:0071800 | podosome assembly(GO:0071800) |
0.5 | 0.5 | GO:0001885 | endothelial cell development(GO:0001885) |
0.5 | 3.7 | GO:0060716 | labyrinthine layer blood vessel development(GO:0060716) |
0.5 | 4.3 | GO:0007405 | neuroblast proliferation(GO:0007405) |
0.5 | 142.4 | GO:0007409 | axonogenesis(GO:0007409) |
0.5 | 1.6 | GO:0010765 | positive regulation of sodium ion transport(GO:0010765) |
0.5 | 2.6 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.5 | 2.6 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
0.5 | 33.2 | GO:0035023 | regulation of Rho protein signal transduction(GO:0035023) |
0.5 | 1.6 | GO:0021707 | cerebellar granular layer development(GO:0021681) cerebellar granular layer morphogenesis(GO:0021683) cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
0.5 | 3.1 | GO:0045070 | positive regulation of viral genome replication(GO:0045070) |
0.5 | 4.1 | GO:1901678 | iron coordination entity transport(GO:1901678) |
0.5 | 3.1 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
0.5 | 0.5 | GO:0001705 | ectoderm formation(GO:0001705) |
0.5 | 4.6 | GO:0034605 | cellular response to heat(GO:0034605) |
0.5 | 2.0 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
0.5 | 1.0 | GO:0016246 | RNA interference(GO:0016246) |
0.5 | 1.5 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
0.5 | 1.0 | GO:0017014 | protein nitrosylation(GO:0017014) peptidyl-cysteine S-nitrosylation(GO:0018119) |
0.5 | 0.5 | GO:0006642 | triglyceride mobilization(GO:0006642) |
0.5 | 0.5 | GO:0021510 | spinal cord development(GO:0021510) |
0.5 | 4.5 | GO:0010633 | negative regulation of epithelial cell migration(GO:0010633) |
0.5 | 8.8 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.5 | 1.9 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
0.5 | 2.4 | GO:0048286 | lung alveolus development(GO:0048286) |
0.5 | 0.5 | GO:0043084 | penile erection(GO:0043084) |
0.5 | 0.5 | GO:0031664 | regulation of lipopolysaccharide-mediated signaling pathway(GO:0031664) |
0.5 | 3.3 | GO:0021987 | cerebral cortex development(GO:0021987) |
0.5 | 0.5 | GO:0001831 | trophectodermal cellular morphogenesis(GO:0001831) |
0.5 | 0.5 | GO:0072393 | microtubule anchoring at microtubule organizing center(GO:0072393) |
0.5 | 0.9 | GO:0060014 | granulosa cell differentiation(GO:0060014) |
0.5 | 1.9 | GO:0006538 | glutamate catabolic process(GO:0006538) |
0.5 | 2.8 | GO:0007520 | syncytium formation by plasma membrane fusion(GO:0000768) myoblast fusion(GO:0007520) |
0.5 | 1.4 | GO:0044803 | multi-organism membrane organization(GO:0044803) |
0.5 | 1.4 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.5 | 0.5 | GO:0001660 | fever generation(GO:0001660) |
0.5 | 0.9 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.5 | 2.7 | GO:0035510 | DNA dealkylation(GO:0035510) |
0.4 | 1.3 | GO:0043949 | regulation of cAMP-mediated signaling(GO:0043949) |
0.4 | 2.2 | GO:0031345 | negative regulation of neuron projection development(GO:0010977) negative regulation of cell projection organization(GO:0031345) |
0.4 | 3.5 | GO:0098743 | cartilage condensation(GO:0001502) cell aggregation(GO:0098743) |
0.4 | 1.3 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.4 | 5.2 | GO:0032400 | melanosome localization(GO:0032400) |
0.4 | 2.2 | GO:0006561 | proline biosynthetic process(GO:0006561) |
0.4 | 2.6 | GO:0015904 | tetracycline transport(GO:0015904) |
0.4 | 58.2 | GO:0006813 | potassium ion transport(GO:0006813) |
0.4 | 1.3 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.4 | 3.4 | GO:0046386 | deoxyribose phosphate catabolic process(GO:0046386) |
0.4 | 1.3 | GO:0007512 | adult heart development(GO:0007512) |
0.4 | 1.7 | GO:0008088 | axo-dendritic transport(GO:0008088) |
0.4 | 0.9 | GO:0048808 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
0.4 | 1.3 | GO:0045980 | negative regulation of nucleotide metabolic process(GO:0045980) |
0.4 | 8.0 | GO:0032436 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032436) positive regulation of proteasomal protein catabolic process(GO:1901800) |
0.4 | 2.1 | GO:0035115 | embryonic forelimb morphogenesis(GO:0035115) |
0.4 | 3.4 | GO:0046685 | response to arsenic-containing substance(GO:0046685) |
0.4 | 7.1 | GO:0001539 | cilium or flagellum-dependent cell motility(GO:0001539) |
0.4 | 8.8 | GO:0030198 | extracellular matrix organization(GO:0030198) extracellular structure organization(GO:0043062) |
0.4 | 1.7 | GO:0009136 | ADP biosynthetic process(GO:0006172) purine nucleoside diphosphate biosynthetic process(GO:0009136) purine ribonucleoside diphosphate biosynthetic process(GO:0009180) ribonucleoside diphosphate biosynthetic process(GO:0009188) |
0.4 | 1.2 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
0.4 | 7.1 | GO:0031032 | actomyosin structure organization(GO:0031032) |
0.4 | 1.6 | GO:0043457 | regulation of cellular respiration(GO:0043457) |
0.4 | 4.9 | GO:0030810 | positive regulation of cyclic nucleotide biosynthetic process(GO:0030804) positive regulation of nucleotide biosynthetic process(GO:0030810) positive regulation of cAMP metabolic process(GO:0030816) positive regulation of cAMP biosynthetic process(GO:0030819) positive regulation of purine nucleotide biosynthetic process(GO:1900373) |
0.4 | 4.1 | GO:0046888 | negative regulation of hormone secretion(GO:0046888) |
0.4 | 2.4 | GO:0007176 | regulation of epidermal growth factor-activated receptor activity(GO:0007176) |
0.4 | 2.0 | GO:0002011 | morphogenesis of an epithelial sheet(GO:0002011) |
0.4 | 2.8 | GO:0033189 | response to vitamin A(GO:0033189) |
0.4 | 0.4 | GO:0071320 | cellular response to cAMP(GO:0071320) |
0.4 | 1.2 | GO:0003010 | voluntary skeletal muscle contraction(GO:0003010) twitch skeletal muscle contraction(GO:0014721) |
0.4 | 4.8 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.4 | 1.6 | GO:0043276 | anoikis(GO:0043276) |
0.4 | 0.8 | GO:0007494 | midgut development(GO:0007494) |
0.4 | 0.8 | GO:0042693 | muscle cell fate commitment(GO:0042693) |
0.4 | 0.4 | GO:0014821 | phasic smooth muscle contraction(GO:0014821) |
0.4 | 0.8 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) chloride ion homeostasis(GO:0055064) |
0.4 | 1.6 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
0.4 | 1.5 | GO:0032528 | microvillus assembly(GO:0030033) microvillus organization(GO:0032528) |
0.4 | 3.1 | GO:0000038 | very long-chain fatty acid metabolic process(GO:0000038) |
0.4 | 0.4 | GO:0051594 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
0.4 | 0.4 | GO:0035590 | purinergic receptor signaling pathway(GO:0035587) purinergic nucleotide receptor signaling pathway(GO:0035590) |
0.4 | 6.8 | GO:0007266 | Rho protein signal transduction(GO:0007266) |
0.4 | 2.3 | GO:0046498 | S-adenosylhomocysteine metabolic process(GO:0046498) |
0.4 | 0.4 | GO:0051955 | regulation of amino acid transport(GO:0051955) |
0.4 | 0.8 | GO:0032525 | somite rostral/caudal axis specification(GO:0032525) |
0.4 | 0.4 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
0.4 | 1.8 | GO:0061098 | positive regulation of protein tyrosine kinase activity(GO:0061098) |
0.4 | 0.4 | GO:0042220 | response to cocaine(GO:0042220) |
0.4 | 2.5 | GO:0048839 | inner ear development(GO:0048839) |
0.4 | 0.4 | GO:0070423 | cytoplasmic pattern recognition receptor signaling pathway(GO:0002753) nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway(GO:0035872) nucleotide-binding oligomerization domain containing signaling pathway(GO:0070423) nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070431) |
0.4 | 1.1 | GO:0072502 | cellular phosphate ion homeostasis(GO:0030643) cellular divalent inorganic anion homeostasis(GO:0072501) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.4 | 0.4 | GO:0061101 | neuroendocrine cell differentiation(GO:0061101) |
0.4 | 1.4 | GO:0050872 | white fat cell differentiation(GO:0050872) |
0.4 | 0.4 | GO:0010269 | response to selenium ion(GO:0010269) |
0.4 | 3.9 | GO:0030514 | negative regulation of BMP signaling pathway(GO:0030514) |
0.3 | 0.7 | GO:0019532 | oxalate transport(GO:0019532) |
0.3 | 2.8 | GO:0043392 | negative regulation of DNA binding(GO:0043392) |
0.3 | 4.8 | GO:0031572 | G2 DNA damage checkpoint(GO:0031572) |
0.3 | 0.3 | GO:0031529 | ruffle organization(GO:0031529) |
0.3 | 1.0 | GO:0046655 | folic acid metabolic process(GO:0046655) |
0.3 | 2.0 | GO:0042977 | activation of JAK2 kinase activity(GO:0042977) |
0.3 | 4.4 | GO:0035336 | long-chain fatty-acyl-CoA metabolic process(GO:0035336) long-chain fatty-acyl-CoA biosynthetic process(GO:0035338) |
0.3 | 0.3 | GO:0090400 | stress-induced premature senescence(GO:0090400) |
0.3 | 1.0 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
0.3 | 0.3 | GO:0048617 | foregut morphogenesis(GO:0007440) embryonic foregut morphogenesis(GO:0048617) |
0.3 | 2.3 | GO:0060415 | muscle tissue morphogenesis(GO:0060415) |
0.3 | 0.7 | GO:0071300 | cellular response to retinoic acid(GO:0071300) |
0.3 | 2.0 | GO:0042730 | fibrinolysis(GO:0042730) |
0.3 | 2.0 | GO:0051918 | negative regulation of fibrinolysis(GO:0051918) |
0.3 | 7.5 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
0.3 | 0.6 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
0.3 | 1.3 | GO:0061053 | somite development(GO:0061053) |
0.3 | 0.3 | GO:0010002 | cardioblast differentiation(GO:0010002) |
0.3 | 0.3 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
0.3 | 4.1 | GO:0006699 | bile acid biosynthetic process(GO:0006699) |
0.3 | 0.6 | GO:0035176 | social behavior(GO:0035176) intraspecies interaction between organisms(GO:0051703) |
0.3 | 0.9 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
0.3 | 0.3 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.3 | 3.5 | GO:0046415 | urate metabolic process(GO:0046415) |
0.3 | 0.6 | GO:0045446 | endothelial cell differentiation(GO:0045446) |
0.3 | 26.4 | GO:0001525 | angiogenesis(GO:0001525) |
0.3 | 0.6 | GO:0070373 | negative regulation of ERK1 and ERK2 cascade(GO:0070373) |
0.3 | 1.9 | GO:0046326 | positive regulation of glucose import(GO:0046326) |
0.3 | 4.0 | GO:0006821 | chloride transport(GO:0006821) |
0.3 | 0.6 | GO:0043587 | tongue morphogenesis(GO:0043587) |
0.3 | 0.9 | GO:0034063 | stress granule assembly(GO:0034063) |
0.3 | 0.9 | GO:0019695 | choline metabolic process(GO:0019695) |
0.3 | 4.4 | GO:0046847 | filopodium assembly(GO:0046847) |
0.3 | 0.9 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) protein side chain deglutamylation(GO:0035610) |
0.3 | 0.6 | GO:0046838 | phosphorylated carbohydrate dephosphorylation(GO:0046838) inositol phosphate dephosphorylation(GO:0046855) |
0.3 | 0.3 | GO:0070508 | sterol import(GO:0035376) cholesterol import(GO:0070508) |
0.3 | 2.1 | GO:0035437 | protein retention in ER lumen(GO:0006621) maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
0.3 | 0.3 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.3 | 0.3 | GO:0048713 | regulation of oligodendrocyte differentiation(GO:0048713) |
0.3 | 5.0 | GO:0048706 | embryonic skeletal system development(GO:0048706) |
0.3 | 1.2 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
0.3 | 0.6 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
0.3 | 0.3 | GO:0003156 | regulation of organ formation(GO:0003156) |
0.3 | 1.2 | GO:0045445 | myoblast differentiation(GO:0045445) |
0.3 | 0.3 | GO:2000179 | positive regulation of neural precursor cell proliferation(GO:2000179) |
0.3 | 7.2 | GO:0051291 | protein heterooligomerization(GO:0051291) |
0.3 | 4.9 | GO:0008584 | male gonad development(GO:0008584) development of primary male sexual characteristics(GO:0046546) |
0.3 | 0.9 | GO:0034629 | cellular protein complex localization(GO:0034629) |
0.3 | 20.6 | GO:0006814 | sodium ion transport(GO:0006814) |
0.3 | 1.4 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
0.3 | 0.8 | GO:0000966 | RNA 5'-end processing(GO:0000966) |
0.3 | 1.1 | GO:0043588 | skin development(GO:0043588) |
0.3 | 0.5 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.3 | 1.6 | GO:0051101 | regulation of DNA binding(GO:0051101) |
0.3 | 1.6 | GO:0042135 | neurotransmitter catabolic process(GO:0042135) |
0.3 | 1.1 | GO:0010226 | response to lithium ion(GO:0010226) |
0.3 | 0.5 | GO:0006560 | proline metabolic process(GO:0006560) |
0.3 | 2.9 | GO:0045995 | regulation of embryonic development(GO:0045995) |
0.3 | 4.2 | GO:0019433 | triglyceride catabolic process(GO:0019433) |
0.3 | 1.3 | GO:0044705 | mating behavior(GO:0007617) multi-organism reproductive behavior(GO:0044705) |
0.3 | 1.0 | GO:0045806 | negative regulation of endocytosis(GO:0045806) |
0.3 | 1.8 | GO:0007007 | inner mitochondrial membrane organization(GO:0007007) |
0.3 | 0.3 | GO:0015705 | iodide transport(GO:0015705) |
0.3 | 0.3 | GO:0031639 | plasminogen activation(GO:0031639) |
0.3 | 0.3 | GO:0032071 | regulation of endodeoxyribonuclease activity(GO:0032071) |
0.3 | 2.3 | GO:0051567 | histone H3-K9 methylation(GO:0051567) histone H3-K9 modification(GO:0061647) |
0.3 | 0.3 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.3 | 0.8 | GO:0030219 | megakaryocyte differentiation(GO:0030219) |
0.3 | 0.3 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
0.2 | 0.5 | GO:0002328 | pro-B cell differentiation(GO:0002328) |
0.2 | 1.0 | GO:0090130 | tissue migration(GO:0090130) |
0.2 | 1.0 | GO:0050905 | neuromuscular process(GO:0050905) |
0.2 | 2.2 | GO:1900182 | positive regulation of protein import into nucleus(GO:0042307) positive regulation of protein localization to nucleus(GO:1900182) positive regulation of protein import(GO:1904591) |
0.2 | 0.7 | GO:0016265 | obsolete death(GO:0016265) |
0.2 | 1.0 | GO:0045668 | negative regulation of osteoblast differentiation(GO:0045668) |
0.2 | 1.7 | GO:0001843 | neural tube closure(GO:0001843) |
0.2 | 0.2 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
0.2 | 0.7 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.2 | 1.2 | GO:0001573 | ganglioside metabolic process(GO:0001573) |
0.2 | 0.2 | GO:0032095 | regulation of response to food(GO:0032095) |
0.2 | 1.4 | GO:0007340 | acrosome reaction(GO:0007340) |
0.2 | 0.9 | GO:0043154 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic process(GO:0043154) |
0.2 | 1.7 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
0.2 | 2.8 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.2 | 0.2 | GO:0042074 | cell migration involved in gastrulation(GO:0042074) |
0.2 | 1.8 | GO:0045807 | positive regulation of endocytosis(GO:0045807) |
0.2 | 0.5 | GO:0008054 | negative regulation of cyclin-dependent protein serine/threonine kinase by cyclin degradation(GO:0008054) |
0.2 | 1.6 | GO:0051205 | protein insertion into membrane(GO:0051205) |
0.2 | 0.2 | GO:0070059 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0070059) |
0.2 | 1.6 | GO:0048813 | dendrite morphogenesis(GO:0048813) |
0.2 | 0.5 | GO:0007431 | salivary gland development(GO:0007431) |
0.2 | 0.2 | GO:0044240 | multicellular organism lipid catabolic process(GO:0044240) |
0.2 | 6.4 | GO:0050890 | cognition(GO:0050890) |
0.2 | 0.2 | GO:0032465 | regulation of cytokinesis(GO:0032465) |
0.2 | 4.5 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.2 | 1.8 | GO:0015949 | nucleobase-containing small molecule interconversion(GO:0015949) |
0.2 | 1.6 | GO:0090263 | positive regulation of canonical Wnt signaling pathway(GO:0090263) |
0.2 | 0.9 | GO:0000052 | citrulline metabolic process(GO:0000052) |
0.2 | 4.2 | GO:0070252 | muscle filament sliding(GO:0030049) actin-myosin filament sliding(GO:0033275) actin-mediated cell contraction(GO:0070252) |
0.2 | 0.4 | GO:0006533 | aspartate metabolic process(GO:0006531) aspartate catabolic process(GO:0006533) |
0.2 | 1.3 | GO:0043525 | positive regulation of neuron apoptotic process(GO:0043525) positive regulation of neuron death(GO:1901216) |
0.2 | 1.1 | GO:0050931 | melanocyte differentiation(GO:0030318) pigment cell differentiation(GO:0050931) |
0.2 | 0.7 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) tetrahydrobiopterin metabolic process(GO:0046146) |
0.2 | 0.2 | GO:0071635 | negative regulation of transforming growth factor beta production(GO:0071635) |
0.2 | 0.7 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.2 | 0.2 | GO:0010171 | body morphogenesis(GO:0010171) |
0.2 | 2.6 | GO:0030509 | BMP signaling pathway(GO:0030509) response to BMP(GO:0071772) cellular response to BMP stimulus(GO:0071773) |
0.2 | 1.7 | GO:0018149 | peptide cross-linking(GO:0018149) |
0.2 | 0.2 | GO:0035121 | obsolete tail morphogenesis(GO:0035121) |
0.2 | 0.9 | GO:0030488 | tRNA methylation(GO:0030488) |
0.2 | 7.0 | GO:0008544 | epidermis development(GO:0008544) |
0.2 | 4.9 | GO:0006308 | DNA catabolic process(GO:0006308) |
0.2 | 2.5 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.2 | 0.6 | GO:0050667 | homocysteine metabolic process(GO:0050667) |
0.2 | 3.2 | GO:0048736 | appendage development(GO:0048736) limb development(GO:0060173) |
0.2 | 1.1 | GO:0046149 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
0.2 | 0.6 | GO:0090292 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
0.2 | 5.2 | GO:0007588 | excretion(GO:0007588) |
0.2 | 2.5 | GO:0007368 | determination of left/right symmetry(GO:0007368) |
0.2 | 5.2 | GO:0017148 | negative regulation of translation(GO:0017148) negative regulation of cellular amide metabolic process(GO:0034249) |
0.2 | 1.0 | GO:0007130 | synaptonemal complex assembly(GO:0007130) |
0.2 | 0.2 | GO:0010040 | response to iron(II) ion(GO:0010040) |
0.2 | 1.6 | GO:0006554 | lysine metabolic process(GO:0006553) lysine catabolic process(GO:0006554) |
0.2 | 2.1 | GO:0009311 | oligosaccharide metabolic process(GO:0009311) |
0.2 | 0.2 | GO:0042268 | regulation of cytolysis(GO:0042268) |
0.2 | 0.6 | GO:0032410 | negative regulation of transporter activity(GO:0032410) |
0.2 | 0.6 | GO:0009133 | nucleoside diphosphate biosynthetic process(GO:0009133) |
0.2 | 1.0 | GO:0007212 | dopamine receptor signaling pathway(GO:0007212) |
0.2 | 1.2 | GO:0006937 | regulation of muscle contraction(GO:0006937) |
0.2 | 3.4 | GO:0051216 | cartilage development(GO:0051216) |
0.2 | 0.2 | GO:1901160 | serotonin metabolic process(GO:0042428) primary amino compound metabolic process(GO:1901160) |
0.2 | 6.2 | GO:0030111 | regulation of Wnt signaling pathway(GO:0030111) |
0.2 | 0.2 | GO:0003382 | epithelial cell morphogenesis(GO:0003382) |
0.2 | 1.6 | GO:0015074 | DNA integration(GO:0015074) |
0.2 | 0.2 | GO:0045945 | positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
0.2 | 0.4 | GO:0007100 | mitotic centrosome separation(GO:0007100) |
0.2 | 1.5 | GO:0032784 | regulation of DNA-templated transcription, elongation(GO:0032784) |
0.2 | 0.8 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.2 | 0.2 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
0.2 | 0.8 | GO:0009409 | response to cold(GO:0009409) |
0.2 | 0.6 | GO:0030901 | midbrain development(GO:0030901) |
0.2 | 0.2 | GO:0090311 | regulation of protein deacetylation(GO:0090311) positive regulation of protein deacetylation(GO:0090312) |
0.2 | 0.4 | GO:0009106 | lipoate metabolic process(GO:0009106) |
0.2 | 0.8 | GO:0043030 | regulation of macrophage activation(GO:0043030) |
0.2 | 1.5 | GO:0008272 | sulfate transport(GO:0008272) |
0.2 | 7.0 | GO:0008277 | regulation of G-protein coupled receptor protein signaling pathway(GO:0008277) |
0.2 | 0.6 | GO:0006208 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
0.2 | 2.2 | GO:0071577 | zinc II ion transmembrane transport(GO:0071577) |
0.2 | 16.9 | GO:0043087 | regulation of GTPase activity(GO:0043087) |
0.2 | 0.2 | GO:0006817 | phosphate ion transport(GO:0006817) |
0.2 | 1.8 | GO:0007141 | male meiosis I(GO:0007141) |
0.2 | 2.1 | GO:0051925 | obsolete regulation of calcium ion transport via voltage-gated calcium channel activity(GO:0051925) |
0.2 | 1.5 | GO:0048008 | platelet-derived growth factor receptor signaling pathway(GO:0048008) |
0.2 | 0.8 | GO:0042438 | melanin biosynthetic process(GO:0042438) |
0.2 | 0.2 | GO:0032674 | interleukin-5 production(GO:0032634) regulation of interleukin-5 production(GO:0032674) |
0.2 | 0.3 | GO:0010826 | negative regulation of centrosome duplication(GO:0010826) negative regulation of centrosome cycle(GO:0046606) |
0.2 | 0.8 | GO:0042246 | tissue regeneration(GO:0042246) |
0.2 | 0.3 | GO:0036473 | intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0008631) cell death in response to oxidative stress(GO:0036473) |
0.2 | 0.3 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
0.2 | 0.3 | GO:0045650 | negative regulation of macrophage differentiation(GO:0045650) |
0.2 | 0.5 | GO:0045604 | regulation of epidermal cell differentiation(GO:0045604) |
0.2 | 1.2 | GO:0007566 | embryo implantation(GO:0007566) |
0.2 | 0.8 | GO:0070207 | protein homotrimerization(GO:0070207) |
0.2 | 0.2 | GO:0031268 | pseudopodium organization(GO:0031268) |
0.2 | 0.9 | GO:0033273 | response to vitamin(GO:0033273) |
0.1 | 1.0 | GO:0015695 | organic cation transport(GO:0015695) |
0.1 | 0.4 | GO:0034501 | protein localization to kinetochore(GO:0034501) |
0.1 | 0.1 | GO:0048483 | autonomic nervous system development(GO:0048483) |
0.1 | 0.7 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.1 | 0.3 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
0.1 | 0.6 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.1 | 0.9 | GO:0018065 | protein-cofactor linkage(GO:0018065) |
0.1 | 0.1 | GO:0032354 | response to follicle-stimulating hormone(GO:0032354) |
0.1 | 0.1 | GO:0014037 | Schwann cell differentiation(GO:0014037) |
0.1 | 0.3 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.1 | 0.1 | GO:0009296 | obsolete flagellum assembly(GO:0009296) |
0.1 | 0.1 | GO:1903727 | positive regulation of phospholipid metabolic process(GO:1903727) |
0.1 | 0.5 | GO:0046457 | prostaglandin biosynthetic process(GO:0001516) prostanoid biosynthetic process(GO:0046457) |
0.1 | 0.5 | GO:0042574 | retinal metabolic process(GO:0042574) |
0.1 | 0.8 | GO:0007026 | negative regulation of microtubule depolymerization(GO:0007026) |
0.1 | 0.4 | GO:0001508 | action potential(GO:0001508) |
0.1 | 0.1 | GO:0048588 | developmental cell growth(GO:0048588) |
0.1 | 0.1 | GO:0002021 | response to dietary excess(GO:0002021) |
0.1 | 0.7 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
0.1 | 0.4 | GO:0006983 | ER overload response(GO:0006983) |
0.1 | 0.4 | GO:0044314 | protein K27-linked ubiquitination(GO:0044314) |
0.1 | 9.7 | GO:0061061 | muscle structure development(GO:0061061) |
0.1 | 0.4 | GO:0006622 | protein targeting to lysosome(GO:0006622) protein targeting to vacuole(GO:0006623) protein localization to lysosome(GO:0061462) protein localization to vacuole(GO:0072665) establishment of protein localization to vacuole(GO:0072666) |
0.1 | 0.1 | GO:0070254 | mucus secretion(GO:0070254) |
0.1 | 0.7 | GO:0030100 | regulation of endocytosis(GO:0030100) |
0.1 | 0.1 | GO:0006855 | drug transmembrane transport(GO:0006855) |
0.1 | 2.9 | GO:0008543 | fibroblast growth factor receptor signaling pathway(GO:0008543) |
0.1 | 0.1 | GO:2000117 | negative regulation of cysteine-type endopeptidase activity(GO:2000117) |
0.1 | 0.1 | GO:0014888 | striated muscle adaptation(GO:0014888) |
0.1 | 0.2 | GO:0030878 | thyroid gland development(GO:0030878) |
0.1 | 6.4 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.1 | 0.1 | GO:0006565 | L-serine catabolic process(GO:0006565) |
0.1 | 0.1 | GO:0045821 | positive regulation of nucleotide catabolic process(GO:0030813) positive regulation of glycolytic process(GO:0045821) positive regulation of nucleoside metabolic process(GO:0045979) positive regulation of cofactor metabolic process(GO:0051194) positive regulation of coenzyme metabolic process(GO:0051197) positive regulation of ATP metabolic process(GO:1903580) |
0.1 | 5.3 | GO:0034329 | cell junction assembly(GO:0034329) |
0.1 | 1.8 | GO:0007626 | locomotory behavior(GO:0007626) |
0.1 | 1.5 | GO:0030216 | keratinocyte differentiation(GO:0030216) |
0.1 | 1.8 | GO:0048477 | oogenesis(GO:0048477) |
0.1 | 0.3 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.1 | 0.2 | GO:0019731 | antimicrobial humoral response(GO:0019730) antibacterial humoral response(GO:0019731) |
0.1 | 0.1 | GO:0045056 | transcytosis(GO:0045056) |
0.1 | 0.2 | GO:0060056 | mammary gland involution(GO:0060056) |
0.1 | 2.8 | GO:0031175 | neuron projection development(GO:0031175) |
0.1 | 0.1 | GO:0006907 | pinocytosis(GO:0006907) |
0.1 | 0.1 | GO:0033148 | positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
0.1 | 1.0 | GO:0050427 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
0.1 | 0.1 | GO:0072234 | metanephric tubule development(GO:0072170) metanephric epithelium development(GO:0072207) metanephric nephron tubule development(GO:0072234) metanephric nephron epithelium development(GO:0072243) |
0.1 | 0.2 | GO:0002327 | immature B cell differentiation(GO:0002327) pre-B cell differentiation(GO:0002329) |
0.1 | 3.6 | GO:0030308 | negative regulation of cell growth(GO:0030308) |
0.1 | 1.7 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
0.1 | 0.1 | GO:0046325 | negative regulation of glucose import(GO:0046325) |
0.1 | 0.3 | GO:0042178 | xenobiotic catabolic process(GO:0042178) |
0.1 | 0.4 | GO:0046040 | IMP biosynthetic process(GO:0006188) IMP metabolic process(GO:0046040) |
0.1 | 0.3 | GO:0007598 | blood coagulation, extrinsic pathway(GO:0007598) |
0.1 | 0.1 | GO:0009151 | purine deoxyribonucleotide metabolic process(GO:0009151) |
0.1 | 0.3 | GO:0034105 | positive regulation of tissue remodeling(GO:0034105) |
0.1 | 0.2 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.1 | 1.1 | GO:0051781 | positive regulation of cell division(GO:0051781) |
0.1 | 0.1 | GO:0070244 | negative regulation of thymocyte apoptotic process(GO:0070244) |
0.1 | 0.4 | GO:0006548 | histidine catabolic process(GO:0006548) imidazole-containing compound catabolic process(GO:0052805) |
0.1 | 0.6 | GO:0009268 | response to pH(GO:0009268) |
0.1 | 0.4 | GO:0044241 | lipid digestion(GO:0044241) |
0.1 | 0.1 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
0.1 | 0.1 | GO:0034085 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
0.1 | 0.3 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.1 | 0.3 | GO:0006700 | C21-steroid hormone biosynthetic process(GO:0006700) |
0.1 | 0.4 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.1 | 0.1 | GO:0060155 | platelet dense granule organization(GO:0060155) |
0.1 | 0.4 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
0.1 | 0.3 | GO:0017187 | peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
0.1 | 0.8 | GO:0010811 | positive regulation of cell-substrate adhesion(GO:0010811) |
0.1 | 0.1 | GO:0048854 | brain morphogenesis(GO:0048854) |
0.1 | 0.1 | GO:0000212 | meiotic spindle organization(GO:0000212) |
0.1 | 0.1 | GO:0032924 | activin receptor signaling pathway(GO:0032924) regulation of activin receptor signaling pathway(GO:0032925) |
0.1 | 0.3 | GO:0006857 | oligopeptide transport(GO:0006857) |
0.1 | 0.1 | GO:0048532 | anatomical structure arrangement(GO:0048532) |
0.1 | 0.4 | GO:0015858 | nucleoside transport(GO:0015858) |
0.1 | 5.1 | GO:0007018 | microtubule-based movement(GO:0007018) |
0.1 | 0.6 | GO:0008211 | glucocorticoid metabolic process(GO:0008211) |
0.1 | 22.5 | GO:0007399 | nervous system development(GO:0007399) |
0.1 | 0.2 | GO:0042417 | dopamine metabolic process(GO:0042417) |
0.1 | 0.1 | GO:0043649 | dicarboxylic acid catabolic process(GO:0043649) |
0.1 | 0.2 | GO:0006684 | sphingomyelin metabolic process(GO:0006684) |
0.1 | 0.1 | GO:0010944 | negative regulation of transcription by competitive promoter binding(GO:0010944) |
0.1 | 0.7 | GO:0009791 | post-embryonic development(GO:0009791) |
0.1 | 0.1 | GO:0035272 | exocrine system development(GO:0035272) |
0.1 | 2.2 | GO:0031638 | zymogen activation(GO:0031638) |
0.1 | 0.6 | GO:0006476 | protein deacetylation(GO:0006476) |
0.1 | 1.4 | GO:0006898 | receptor-mediated endocytosis(GO:0006898) |
0.1 | 0.1 | GO:0048066 | developmental pigmentation(GO:0048066) |
0.1 | 0.2 | GO:0015810 | C4-dicarboxylate transport(GO:0015740) aspartate transport(GO:0015810) |
0.1 | 0.5 | GO:0090101 | negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway(GO:0090101) |
0.1 | 0.1 | GO:0051588 | regulation of neurotransmitter transport(GO:0051588) |
0.1 | 0.1 | GO:0030952 | establishment or maintenance of cytoskeleton polarity(GO:0030952) |
0.1 | 0.1 | GO:0048539 | bone marrow development(GO:0048539) |
0.1 | 0.4 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.1 | 0.1 | GO:0015844 | monoamine transport(GO:0015844) |
0.1 | 0.6 | GO:0010952 | positive regulation of peptidase activity(GO:0010952) |
0.1 | 0.4 | GO:0098543 | detection of bacterium(GO:0016045) detection of other organism(GO:0098543) |
0.1 | 0.2 | GO:0030277 | epithelial structure maintenance(GO:0010669) maintenance of gastrointestinal epithelium(GO:0030277) |
0.1 | 1.4 | GO:0015682 | ferric iron transport(GO:0015682) transferrin transport(GO:0033572) trivalent inorganic cation transport(GO:0072512) |
0.1 | 0.1 | GO:0000019 | regulation of mitotic recombination(GO:0000019) |
0.1 | 0.1 | GO:0001829 | trophectodermal cell differentiation(GO:0001829) |
0.1 | 0.2 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) maturation of LSU-rRNA(GO:0000470) |
0.1 | 0.1 | GO:0030490 | maturation of SSU-rRNA(GO:0030490) |
0.1 | 1.9 | GO:0006936 | muscle contraction(GO:0006936) |
0.1 | 0.6 | GO:0042255 | ribosome assembly(GO:0042255) |
0.1 | 0.4 | GO:0043473 | pigmentation(GO:0043473) |
0.1 | 0.4 | GO:0006067 | ethanol metabolic process(GO:0006067) ethanol oxidation(GO:0006069) |
0.1 | 0.1 | GO:0009109 | coenzyme catabolic process(GO:0009109) |
0.0 | 0.1 | GO:0045905 | translational frameshifting(GO:0006452) positive regulation of translational elongation(GO:0045901) positive regulation of translational termination(GO:0045905) |
0.0 | 0.1 | GO:0006515 | misfolded or incompletely synthesized protein catabolic process(GO:0006515) |
0.0 | 0.2 | GO:0072595 | maintenance of protein localization in organelle(GO:0072595) |
0.0 | 0.1 | GO:0015824 | proline transport(GO:0015824) |
0.0 | 0.0 | GO:0060644 | mammary gland epithelial cell differentiation(GO:0060644) |
0.0 | 0.0 | GO:0046113 | nucleobase catabolic process(GO:0046113) |
0.0 | 0.0 | GO:0032106 | positive regulation of response to extracellular stimulus(GO:0032106) positive regulation of response to nutrient levels(GO:0032109) |
0.0 | 0.0 | GO:0051182 | coenzyme transport(GO:0051182) |
0.0 | 0.1 | GO:0015760 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.0 | 0.1 | GO:0007620 | copulation(GO:0007620) |
0.0 | 0.2 | GO:1900046 | regulation of blood coagulation(GO:0030193) regulation of hemostasis(GO:1900046) |
0.0 | 0.1 | GO:0048169 | regulation of long-term neuronal synaptic plasticity(GO:0048169) |
0.0 | 0.3 | GO:0009712 | catecholamine metabolic process(GO:0006584) catechol-containing compound metabolic process(GO:0009712) |
0.0 | 0.2 | GO:1901880 | negative regulation of protein depolymerization(GO:1901880) |
0.0 | 0.1 | GO:0033261 | obsolete regulation of S phase(GO:0033261) |
0.0 | 0.0 | GO:0003197 | endocardial cushion development(GO:0003197) |
0.0 | 0.1 | GO:0020027 | hemoglobin metabolic process(GO:0020027) |
0.0 | 0.1 | GO:0010039 | response to iron ion(GO:0010039) |
0.0 | 0.0 | GO:0060395 | SMAD protein signal transduction(GO:0060395) |
0.0 | 0.0 | GO:0046689 | response to mercury ion(GO:0046689) |
0.0 | 0.1 | GO:0009143 | nucleoside triphosphate catabolic process(GO:0009143) |
0.0 | 3.1 | GO:0007601 | visual perception(GO:0007601) sensory perception of light stimulus(GO:0050953) |
0.0 | 0.1 | GO:0043496 | regulation of protein homodimerization activity(GO:0043496) |
0.0 | 0.1 | GO:0015988 | energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) ATP hydrolysis coupled transmembrane transport(GO:0090662) |
0.0 | 0.1 | GO:0000012 | single strand break repair(GO:0000012) |
0.0 | 0.0 | GO:0047484 | regulation of response to osmotic stress(GO:0047484) |
0.0 | 0.1 | GO:0018958 | phenol-containing compound metabolic process(GO:0018958) |
0.0 | 0.0 | GO:0051771 | negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
0.0 | 0.0 | GO:0046839 | phospholipid dephosphorylation(GO:0046839) |
0.0 | 0.0 | GO:0031427 | response to methotrexate(GO:0031427) |
0.0 | 0.0 | GO:0010744 | positive regulation of macrophage derived foam cell differentiation(GO:0010744) |
0.0 | 0.0 | GO:0035461 | vitamin transmembrane transport(GO:0035461) |
0.0 | 0.1 | GO:0019236 | response to pheromone(GO:0019236) |
0.0 | 0.0 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
0.0 | 0.3 | GO:0006363 | termination of RNA polymerase I transcription(GO:0006363) |
0.0 | 0.0 | GO:0016102 | retinoic acid biosynthetic process(GO:0002138) diterpenoid biosynthetic process(GO:0016102) |
0.0 | 0.1 | GO:0006385 | transcription elongation from RNA polymerase III promoter(GO:0006385) termination of RNA polymerase III transcription(GO:0006386) |
0.0 | 0.1 | GO:0042475 | odontogenesis of dentin-containing tooth(GO:0042475) |
0.0 | 0.0 | GO:0001302 | replicative cell aging(GO:0001302) |
0.0 | 0.0 | GO:0051339 | regulation of lyase activity(GO:0051339) |
0.0 | 0.0 | GO:0015670 | carbon dioxide transport(GO:0015670) |
0.0 | 0.1 | GO:0070989 | oxidative demethylation(GO:0070989) |
0.0 | 0.0 | GO:0050892 | intestinal absorption(GO:0050892) |
0.0 | 0.1 | GO:1901222 | activation of NF-kappaB-inducing kinase activity(GO:0007250) NIK/NF-kappaB signaling(GO:0038061) regulation of NIK/NF-kappaB signaling(GO:1901222) positive regulation of NIK/NF-kappaB signaling(GO:1901224) |
0.0 | 0.0 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.0 | 0.3 | GO:0046328 | regulation of JNK cascade(GO:0046328) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.6 | 10.9 | GO:0043259 | laminin-10 complex(GO:0043259) |
3.3 | 19.9 | GO:0001527 | microfibril(GO:0001527) |
3.2 | 9.5 | GO:0030934 | anchoring collagen complex(GO:0030934) |
3.1 | 3.1 | GO:0043260 | laminin-11 complex(GO:0043260) |
2.8 | 16.9 | GO:0010369 | chromocenter(GO:0010369) |
2.7 | 11.0 | GO:0005606 | laminin-1 complex(GO:0005606) |
2.6 | 5.2 | GO:0043083 | synaptic cleft(GO:0043083) |
2.5 | 7.5 | GO:0033270 | paranode region of axon(GO:0033270) |
2.4 | 7.2 | GO:0005588 | collagen type V trimer(GO:0005588) |
2.0 | 6.1 | GO:0005900 | oncostatin-M receptor complex(GO:0005900) |
2.0 | 10.2 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
2.0 | 11.9 | GO:0005587 | collagen type IV trimer(GO:0005587) |
1.9 | 21.2 | GO:0044291 | intercalated disc(GO:0014704) cell-cell contact zone(GO:0044291) |
1.9 | 5.7 | GO:0005589 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
1.9 | 5.6 | GO:0032809 | neuronal cell body membrane(GO:0032809) cell body membrane(GO:0044298) |
1.9 | 9.3 | GO:0071437 | invadopodium(GO:0071437) |
1.8 | 5.5 | GO:0031527 | filopodium membrane(GO:0031527) |
1.8 | 10.9 | GO:0031512 | motile primary cilium(GO:0031512) |
1.8 | 5.3 | GO:0070852 | cell body fiber(GO:0070852) |
1.7 | 1.7 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
1.6 | 12.9 | GO:0030128 | AP-2 adaptor complex(GO:0030122) clathrin coat of endocytic vesicle(GO:0030128) |
1.5 | 25.8 | GO:0009925 | basal plasma membrane(GO:0009925) |
1.5 | 26.9 | GO:0030057 | desmosome(GO:0030057) |
1.5 | 4.4 | GO:0005899 | insulin receptor complex(GO:0005899) |
1.5 | 8.9 | GO:0016012 | sarcoglycan complex(GO:0016012) |
1.5 | 5.9 | GO:0005915 | zonula adherens(GO:0005915) |
1.5 | 5.8 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
1.4 | 2.8 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
1.4 | 15.5 | GO:0031528 | microvillus membrane(GO:0031528) |
1.4 | 7.0 | GO:0031258 | lamellipodium membrane(GO:0031258) |
1.4 | 25.0 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
1.3 | 2.7 | GO:0002139 | stereocilia coupling link(GO:0002139) stereocilia ankle link(GO:0002141) stereocilia ankle link complex(GO:0002142) |
1.3 | 10.6 | GO:0043034 | costamere(GO:0043034) |
1.3 | 3.8 | GO:0030673 | axolemma(GO:0030673) |
1.2 | 25.2 | GO:0005581 | collagen trimer(GO:0005581) |
1.2 | 7.2 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
1.2 | 3.5 | GO:0045323 | interleukin-1 receptor complex(GO:0045323) |
1.1 | 24.7 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
1.1 | 4.5 | GO:0031045 | dense core granule(GO:0031045) |
1.1 | 70.5 | GO:0030426 | growth cone(GO:0030426) |
1.1 | 3.3 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
1.1 | 269.6 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
1.0 | 3.1 | GO:0032591 | dendritic spine membrane(GO:0032591) |
1.0 | 5.0 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
1.0 | 4.0 | GO:0016942 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) |
1.0 | 63.5 | GO:0099572 | postsynaptic density(GO:0014069) postsynaptic specialization(GO:0099572) |
1.0 | 9.5 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.9 | 11.4 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.9 | 2.8 | GO:0032449 | CBM complex(GO:0032449) |
0.9 | 2.8 | GO:0042598 | obsolete vesicular fraction(GO:0042598) |
0.9 | 5.6 | GO:0001891 | phagocytic cup(GO:0001891) |
0.9 | 6.5 | GO:0032589 | neuron projection membrane(GO:0032589) |
0.9 | 7.4 | GO:0030315 | T-tubule(GO:0030315) |
0.9 | 1.8 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.9 | 7.9 | GO:0016010 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.9 | 28.5 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.8 | 3.4 | GO:0001740 | Barr body(GO:0001740) |
0.8 | 50.6 | GO:0005923 | bicellular tight junction(GO:0005923) occluding junction(GO:0070160) |
0.8 | 2.4 | GO:0005883 | neurofilament(GO:0005883) |
0.8 | 11.2 | GO:0044447 | axoneme part(GO:0044447) |
0.8 | 4.8 | GO:0005652 | nuclear lamina(GO:0005652) |
0.7 | 37.8 | GO:0031012 | extracellular matrix(GO:0031012) |
0.7 | 3.7 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
0.7 | 75.7 | GO:0005912 | adherens junction(GO:0005912) |
0.7 | 0.7 | GO:0071062 | alphav-beta3 integrin-vitronectin complex(GO:0071062) |
0.7 | 1.4 | GO:0043657 | host(GO:0018995) host cell part(GO:0033643) host intracellular part(GO:0033646) intracellular region of host(GO:0043656) host cell(GO:0043657) other organism(GO:0044215) other organism cell(GO:0044216) other organism part(GO:0044217) |
0.7 | 28.6 | GO:0005901 | caveola(GO:0005901) plasma membrane raft(GO:0044853) |
0.7 | 14.2 | GO:0005796 | Golgi lumen(GO:0005796) |
0.7 | 2.7 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.6 | 1.3 | GO:0000805 | X chromosome(GO:0000805) |
0.6 | 0.6 | GO:0001950 | obsolete plasma membrane enriched fraction(GO:0001950) |
0.6 | 0.6 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.6 | 1.7 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.6 | 1.1 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.6 | 1.7 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.6 | 5.0 | GO:0008091 | spectrin(GO:0008091) |
0.5 | 12.6 | GO:0042383 | sarcolemma(GO:0042383) |
0.5 | 10.9 | GO:0005884 | actin filament(GO:0005884) |
0.5 | 0.5 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.5 | 18.4 | GO:0099501 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.5 | 1.0 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.5 | 15.7 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.5 | 3.9 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.5 | 16.1 | GO:0008021 | synaptic vesicle(GO:0008021) |
0.5 | 2.4 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
0.4 | 1.8 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.4 | 26.7 | GO:0005911 | cell-cell junction(GO:0005911) |
0.4 | 1.7 | GO:0030904 | retromer complex(GO:0030904) |
0.4 | 68.7 | GO:0045202 | synapse(GO:0045202) |
0.4 | 44.9 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.4 | 1.6 | GO:0034704 | calcium channel complex(GO:0034704) |
0.4 | 219.8 | GO:0005615 | extracellular space(GO:0005615) |
0.4 | 16.6 | GO:0030425 | dendrite(GO:0030425) |
0.4 | 1.1 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
0.4 | 1.1 | GO:0001772 | immunological synapse(GO:0001772) |
0.4 | 6.3 | GO:0016460 | myosin II complex(GO:0016460) |
0.4 | 2.6 | GO:0016580 | Sin3 complex(GO:0016580) Sin3-type complex(GO:0070822) |
0.4 | 2.6 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.4 | 3.9 | GO:0071565 | nBAF complex(GO:0071565) |
0.4 | 301.3 | GO:0005887 | integral component of plasma membrane(GO:0005887) |
0.4 | 3.5 | GO:0030175 | filopodium(GO:0030175) |
0.3 | 0.7 | GO:0042589 | zymogen granule membrane(GO:0042589) |
0.3 | 1.4 | GO:0033018 | sarcoplasmic reticulum lumen(GO:0033018) |
0.3 | 3.7 | GO:0030286 | dynein complex(GO:0030286) |
0.3 | 80.7 | GO:0005667 | transcription factor complex(GO:0005667) |
0.3 | 1.6 | GO:0044421 | extracellular region part(GO:0044421) |
0.3 | 1.0 | GO:0032806 | carboxy-terminal domain protein kinase complex(GO:0032806) |
0.3 | 5.4 | GO:0030018 | Z disc(GO:0030018) |
0.3 | 1.9 | GO:0045009 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.3 | 0.3 | GO:0033268 | node of Ranvier(GO:0033268) |
0.3 | 0.9 | GO:0030008 | TRAPP complex(GO:0030008) |
0.3 | 1.8 | GO:0000275 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) |
0.3 | 1.4 | GO:0030870 | Mre11 complex(GO:0030870) |
0.3 | 1.4 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
0.3 | 3.3 | GO:0005833 | hemoglobin complex(GO:0005833) |
0.3 | 1.4 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.3 | 5.0 | GO:0005802 | trans-Golgi network(GO:0005802) |
0.3 | 9.8 | GO:0001726 | ruffle(GO:0001726) |
0.3 | 5.9 | GO:0034707 | chloride channel complex(GO:0034707) |
0.3 | 15.9 | GO:0043005 | neuron projection(GO:0043005) |
0.2 | 4.2 | GO:0005776 | autophagosome(GO:0005776) |
0.2 | 0.7 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.2 | 1.2 | GO:0000801 | central element(GO:0000801) |
0.2 | 6.6 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.2 | 14.7 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.2 | 1.8 | GO:0005861 | troponin complex(GO:0005861) |
0.2 | 2.2 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.2 | 0.4 | GO:0031083 | BLOC complex(GO:0031082) BLOC-1 complex(GO:0031083) |
0.2 | 0.7 | GO:0045277 | mitochondrial respiratory chain complex IV(GO:0005751) respiratory chain complex IV(GO:0045277) |
0.2 | 3.0 | GO:0005811 | lipid particle(GO:0005811) |
0.2 | 2.2 | GO:0005771 | multivesicular body(GO:0005771) |
0.2 | 177.0 | GO:0005576 | extracellular region(GO:0005576) |
0.2 | 6.5 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.2 | 6.0 | GO:0030054 | cell junction(GO:0030054) |
0.2 | 4.1 | GO:0044449 | contractile fiber part(GO:0044449) |
0.2 | 2.3 | GO:0031526 | brush border membrane(GO:0031526) |
0.2 | 1.0 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
0.2 | 0.6 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.2 | 0.8 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.2 | 1.2 | GO:0032421 | stereocilium bundle(GO:0032421) |
0.2 | 1.0 | GO:0071546 | pi-body(GO:0071546) |
0.2 | 0.8 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.2 | 61.5 | GO:0000139 | Golgi membrane(GO:0000139) |
0.2 | 0.9 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.2 | 1.7 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
0.2 | 0.5 | GO:0031091 | platelet alpha granule(GO:0031091) |
0.2 | 10.9 | GO:0005792 | obsolete microsome(GO:0005792) |
0.2 | 0.5 | GO:0071986 | Ragulator complex(GO:0071986) |
0.2 | 0.7 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.2 | 2.7 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.2 | 0.5 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.2 | 0.5 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.2 | 10.0 | GO:0045177 | apical part of cell(GO:0045177) |
0.2 | 0.2 | GO:0005826 | actomyosin contractile ring(GO:0005826) contractile ring(GO:0070938) |
0.2 | 0.5 | GO:0097425 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
0.1 | 408.1 | GO:0016021 | integral component of membrane(GO:0016021) |
0.1 | 0.7 | GO:0033391 | chromatoid body(GO:0033391) |
0.1 | 0.3 | GO:0031143 | pseudopodium(GO:0031143) |
0.1 | 0.4 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.1 | 0.6 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
0.1 | 0.5 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.1 | 0.6 | GO:0000796 | condensin complex(GO:0000796) |
0.1 | 0.3 | GO:0019861 | obsolete flagellum(GO:0019861) |
0.1 | 0.5 | GO:0001739 | sex chromatin(GO:0001739) |
0.1 | 0.1 | GO:0016528 | sarcoplasm(GO:0016528) |
0.1 | 2.8 | GO:0036064 | ciliary basal body(GO:0036064) |
0.1 | 0.4 | GO:0030686 | 90S preribosome(GO:0030686) |
0.1 | 0.8 | GO:0005798 | Golgi-associated vesicle(GO:0005798) |
0.1 | 1.1 | GO:0043073 | germ cell nucleus(GO:0043073) |
0.1 | 1.5 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.1 | 0.1 | GO:0043209 | myelin sheath(GO:0043209) |
0.1 | 0.1 | GO:0045261 | proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
0.1 | 4.5 | GO:0005929 | cilium(GO:0005929) |
0.1 | 1.4 | GO:0016459 | myosin complex(GO:0016459) |
0.0 | 0.2 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.0 | 1.2 | GO:0031901 | early endosome membrane(GO:0031901) |
0.0 | 0.3 | GO:0031984 | organelle subcompartment(GO:0031984) |
0.0 | 3.7 | GO:0005783 | endoplasmic reticulum(GO:0005783) |
0.0 | 0.0 | GO:0031501 | mannosyltransferase complex(GO:0031501) dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.0 | 2.9 | GO:0045095 | keratin filament(GO:0045095) |
0.0 | 0.0 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.0 | 1.3 | GO:0005624 | obsolete membrane fraction(GO:0005624) |
0.0 | 0.4 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.0 | 0.2 | GO:0016272 | prefoldin complex(GO:0016272) |
0.0 | 0.2 | GO:0008274 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
0.0 | 0.1 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.0 | 1.0 | GO:0005875 | microtubule associated complex(GO:0005875) |
0.0 | 0.1 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.0 | 3.0 | GO:0048471 | perinuclear region of cytoplasm(GO:0048471) |
0.0 | 0.2 | GO:0035267 | NuA4 histone acetyltransferase complex(GO:0035267) |
0.0 | 3.3 | GO:0005740 | mitochondrial envelope(GO:0005740) |
0.0 | 0.3 | GO:0044452 | nucleolar part(GO:0044452) |
0.0 | 0.0 | GO:0071547 | piP-body(GO:0071547) |
0.0 | 6.2 | GO:0005856 | cytoskeleton(GO:0005856) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
6.8 | 20.4 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
4.3 | 12.9 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
4.1 | 16.6 | GO:0048495 | Roundabout binding(GO:0048495) |
4.1 | 12.4 | GO:0005017 | platelet-derived growth factor-activated receptor activity(GO:0005017) |
3.9 | 19.4 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
3.7 | 22.1 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
3.5 | 10.6 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
3.5 | 10.4 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
3.4 | 10.3 | GO:0070324 | thyroid hormone binding(GO:0070324) |
3.3 | 9.9 | GO:0003680 | AT DNA binding(GO:0003680) |
3.2 | 9.6 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
3.1 | 15.7 | GO:0070700 | BMP receptor binding(GO:0070700) |
3.0 | 50.6 | GO:0019198 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
2.9 | 8.6 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
2.7 | 8.2 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
2.7 | 8.1 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
2.6 | 18.5 | GO:0005110 | frizzled-2 binding(GO:0005110) |
2.6 | 23.5 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
2.6 | 7.7 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
2.6 | 10.2 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
2.4 | 9.7 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
2.4 | 7.1 | GO:0005152 | interleukin-1 receptor antagonist activity(GO:0005152) |
2.4 | 9.4 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
2.3 | 6.8 | GO:0043394 | proteoglycan binding(GO:0043394) |
2.2 | 8.9 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
2.2 | 6.7 | GO:0015142 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
2.2 | 8.8 | GO:0070215 | obsolete MDM2 binding(GO:0070215) |
2.2 | 6.5 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
2.1 | 6.3 | GO:0019215 | intermediate filament binding(GO:0019215) |
2.1 | 10.4 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
2.1 | 6.2 | GO:0004117 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) |
2.1 | 10.3 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
2.0 | 6.1 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
2.0 | 6.1 | GO:0050698 | proteoglycan sulfotransferase activity(GO:0050698) |
2.0 | 8.0 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
2.0 | 8.0 | GO:0005010 | insulin-like growth factor-activated receptor activity(GO:0005010) |
1.9 | 7.7 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
1.9 | 7.7 | GO:0004470 | malic enzyme activity(GO:0004470) |
1.9 | 23.1 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
1.9 | 11.5 | GO:0042153 | obsolete RPTP-like protein binding(GO:0042153) |
1.9 | 7.6 | GO:0004157 | dihydropyrimidinase activity(GO:0004157) |
1.9 | 5.7 | GO:0008061 | chitin binding(GO:0008061) |
1.9 | 9.4 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
1.8 | 42.5 | GO:0017147 | Wnt-protein binding(GO:0017147) |
1.8 | 7.3 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
1.8 | 10.9 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) ubiquitin-like protein conjugating enzyme binding(GO:0044390) |
1.8 | 12.6 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
1.8 | 5.4 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
1.8 | 1.8 | GO:0001871 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
1.8 | 5.3 | GO:0005113 | patched binding(GO:0005113) |
1.7 | 5.1 | GO:0050682 | AF-2 domain binding(GO:0050682) |
1.7 | 5.1 | GO:0004936 | alpha-adrenergic receptor activity(GO:0004936) |
1.7 | 6.8 | GO:0016004 | phospholipase activator activity(GO:0016004) |
1.7 | 6.7 | GO:0030618 | transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity(GO:0030618) |
1.7 | 6.7 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) peptidyl-proline 4-dioxygenase activity(GO:0031545) |
1.7 | 6.7 | GO:0016934 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
1.6 | 22.9 | GO:0031490 | chromatin DNA binding(GO:0031490) |
1.6 | 4.8 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
1.6 | 6.4 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
1.6 | 8.0 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
1.6 | 4.8 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
1.6 | 6.4 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
1.6 | 4.7 | GO:0005042 | netrin receptor activity(GO:0005042) |
1.6 | 12.5 | GO:0001228 | transcription factor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0000982) transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001228) |
1.5 | 119.0 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
1.5 | 4.6 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
1.5 | 1.5 | GO:0000978 | RNA polymerase II core promoter proximal region sequence-specific DNA binding(GO:0000978) core promoter proximal region sequence-specific DNA binding(GO:0000987) core promoter proximal region DNA binding(GO:0001159) |
1.5 | 10.6 | GO:0017166 | vinculin binding(GO:0017166) |
1.5 | 4.5 | GO:0016151 | nickel cation binding(GO:0016151) |
1.5 | 3.0 | GO:0035254 | glutamate receptor binding(GO:0035254) |
1.5 | 5.9 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
1.5 | 4.4 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
1.5 | 4.4 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
1.5 | 2.9 | GO:0030955 | potassium ion binding(GO:0030955) |
1.4 | 4.3 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
1.4 | 2.8 | GO:0004935 | adrenergic receptor activity(GO:0004935) |
1.4 | 9.8 | GO:0030506 | ankyrin binding(GO:0030506) |
1.4 | 5.5 | GO:0045499 | chemorepellent activity(GO:0045499) |
1.4 | 4.1 | GO:0004500 | dopamine beta-monooxygenase activity(GO:0004500) |
1.4 | 4.1 | GO:0034056 | estrogen response element binding(GO:0034056) |
1.4 | 15.0 | GO:0030553 | cGMP binding(GO:0030553) |
1.4 | 8.2 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
1.3 | 5.4 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) |
1.3 | 4.0 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
1.3 | 2.7 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
1.3 | 4.0 | GO:0050544 | arachidonic acid binding(GO:0050544) |
1.3 | 6.6 | GO:0008517 | folic acid transporter activity(GO:0008517) |
1.3 | 5.2 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
1.3 | 6.5 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
1.3 | 1.3 | GO:0070644 | vitamin D response element binding(GO:0070644) |
1.3 | 7.8 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
1.3 | 3.9 | GO:0004466 | long-chain-acyl-CoA dehydrogenase activity(GO:0004466) |
1.3 | 12.8 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
1.3 | 10.1 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
1.2 | 2.5 | GO:0043495 | protein anchor(GO:0043495) |
1.2 | 7.5 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
1.2 | 6.2 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
1.2 | 7.4 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
1.2 | 8.6 | GO:0042043 | neurexin family protein binding(GO:0042043) |
1.2 | 6.1 | GO:0048406 | nerve growth factor binding(GO:0048406) |
1.2 | 6.1 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
1.2 | 3.6 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
1.2 | 8.3 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
1.2 | 10.5 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
1.1 | 13.8 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
1.1 | 1.1 | GO:0031994 | insulin-like growth factor I binding(GO:0031994) |
1.1 | 10.2 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
1.1 | 18.1 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
1.1 | 9.0 | GO:0050780 | dopamine receptor binding(GO:0050780) |
1.1 | 4.5 | GO:0005227 | calcium activated cation channel activity(GO:0005227) |
1.1 | 6.6 | GO:0008504 | monoamine transmembrane transporter activity(GO:0008504) |
1.1 | 3.3 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
1.1 | 3.3 | GO:0004103 | choline kinase activity(GO:0004103) |
1.1 | 4.4 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
1.1 | 1.1 | GO:0070696 | transmembrane receptor protein serine/threonine kinase binding(GO:0070696) |
1.1 | 8.6 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
1.1 | 1.1 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
1.1 | 3.2 | GO:0004461 | lactose synthase activity(GO:0004461) |
1.1 | 4.3 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
1.1 | 3.2 | GO:0022897 | peptide:proton symporter activity(GO:0015333) proton-dependent peptide secondary active transmembrane transporter activity(GO:0022897) |
1.0 | 15.7 | GO:1905030 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
1.0 | 28.2 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
1.0 | 7.3 | GO:0003706 | obsolete ligand-regulated transcription factor activity(GO:0003706) |
1.0 | 14.5 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
1.0 | 9.3 | GO:0015385 | sodium:proton antiporter activity(GO:0015385) |
1.0 | 10.2 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
1.0 | 3.0 | GO:0019798 | procollagen-proline dioxygenase activity(GO:0019798) |
1.0 | 3.0 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
1.0 | 2.9 | GO:0099602 | acetylcholine receptor regulator activity(GO:0030548) neurotransmitter receptor regulator activity(GO:0099602) |
1.0 | 6.7 | GO:0034483 | heparan sulfate sulfotransferase activity(GO:0034483) |
1.0 | 4.8 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.9 | 2.8 | GO:0005346 | purine ribonucleotide transmembrane transporter activity(GO:0005346) |
0.9 | 4.7 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.9 | 8.4 | GO:0051378 | serotonin binding(GO:0051378) |
0.9 | 2.8 | GO:0016215 | stearoyl-CoA 9-desaturase activity(GO:0004768) acyl-CoA desaturase activity(GO:0016215) |
0.9 | 4.5 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.9 | 3.6 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.9 | 5.4 | GO:0005112 | Notch binding(GO:0005112) |
0.9 | 0.9 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.9 | 2.7 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.9 | 5.4 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.9 | 4.5 | GO:0001085 | RNA polymerase II transcription factor binding(GO:0001085) |
0.9 | 0.9 | GO:0031420 | alkali metal ion binding(GO:0031420) |
0.9 | 7.1 | GO:0015643 | toxic substance binding(GO:0015643) |
0.9 | 3.5 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.9 | 7.1 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.9 | 2.6 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.9 | 4.4 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.9 | 2.6 | GO:0004465 | lipoprotein lipase activity(GO:0004465) |
0.9 | 18.5 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.9 | 2.6 | GO:0055077 | gap junction hemi-channel activity(GO:0055077) |
0.9 | 42.6 | GO:0051015 | actin filament binding(GO:0051015) |
0.9 | 2.6 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.9 | 5.2 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.9 | 1.7 | GO:0016717 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) |
0.8 | 0.8 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.8 | 3.4 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.8 | 4.2 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.8 | 13.4 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
0.8 | 1.7 | GO:0045545 | syndecan binding(GO:0045545) |
0.8 | 8.1 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
0.8 | 9.7 | GO:0001619 | obsolete lysosphingolipid and lysophosphatidic acid receptor activity(GO:0001619) |
0.8 | 2.4 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.8 | 4.0 | GO:0001537 | N-acetylgalactosamine 4-O-sulfotransferase activity(GO:0001537) |
0.8 | 6.4 | GO:0005003 | ephrin receptor activity(GO:0005003) |
0.8 | 2.4 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.8 | 13.4 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.8 | 2.4 | GO:0043274 | phospholipase binding(GO:0043274) |
0.8 | 3.1 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
0.8 | 3.1 | GO:0005522 | profilin binding(GO:0005522) |
0.8 | 0.8 | GO:0048185 | activin binding(GO:0048185) |
0.8 | 5.4 | GO:0005272 | sodium channel activity(GO:0005272) |
0.8 | 2.3 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.8 | 5.3 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.8 | 3.8 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.8 | 8.3 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.7 | 12.0 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.7 | 10.3 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.7 | 3.0 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.7 | 7.3 | GO:0004970 | ionotropic glutamate receptor activity(GO:0004970) |
0.7 | 2.9 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.7 | 2.9 | GO:0030172 | troponin C binding(GO:0030172) |
0.7 | 11.6 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.7 | 2.2 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.7 | 3.6 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
0.7 | 2.1 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.7 | 2.1 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.7 | 56.9 | GO:0008201 | heparin binding(GO:0008201) |
0.7 | 5.0 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
0.7 | 2.1 | GO:0035198 | miRNA binding(GO:0035198) |
0.7 | 4.2 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
0.7 | 2.8 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.7 | 3.4 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) |
0.7 | 21.4 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.7 | 2.7 | GO:0030371 | translation repressor activity(GO:0030371) |
0.7 | 2.0 | GO:0042910 | xenobiotic-transporting ATPase activity(GO:0008559) xenobiotic transporter activity(GO:0042910) |
0.7 | 2.7 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.7 | 10.8 | GO:0004407 | histone deacetylase activity(GO:0004407) |
0.7 | 9.3 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
0.7 | 14.7 | GO:0004714 | transmembrane receptor protein tyrosine kinase activity(GO:0004714) |
0.7 | 4.0 | GO:0051183 | vitamin transporter activity(GO:0051183) |
0.7 | 2.6 | GO:0031685 | adenosine receptor binding(GO:0031685) |
0.6 | 2.6 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.6 | 5.2 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.6 | 71.0 | GO:0008083 | growth factor activity(GO:0008083) |
0.6 | 2.5 | GO:0035252 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.6 | 6.3 | GO:0045296 | cadherin binding(GO:0045296) |
0.6 | 5.1 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.6 | 1.3 | GO:0019534 | toxin transporter activity(GO:0019534) |
0.6 | 5.6 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.6 | 176.3 | GO:0030528 | obsolete transcription regulator activity(GO:0030528) |
0.6 | 1.9 | GO:0042978 | ornithine decarboxylase activator activity(GO:0042978) |
0.6 | 10.5 | GO:0005518 | collagen binding(GO:0005518) |
0.6 | 1.9 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.6 | 1.8 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.6 | 2.4 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
0.6 | 2.4 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.6 | 1.2 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.6 | 1.2 | GO:0000247 | C-8 sterol isomerase activity(GO:0000247) |
0.6 | 1.8 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.6 | 2.9 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.6 | 1.2 | GO:0003960 | NADPH:quinone reductase activity(GO:0003960) |
0.6 | 2.9 | GO:0005314 | high-affinity glutamate transmembrane transporter activity(GO:0005314) |
0.6 | 2.9 | GO:0022821 | potassium ion antiporter activity(GO:0022821) |
0.6 | 4.6 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
0.6 | 2.3 | GO:0047429 | nucleoside-triphosphate diphosphatase activity(GO:0047429) |
0.6 | 1.1 | GO:0004167 | dopachrome isomerase activity(GO:0004167) |
0.6 | 2.2 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.6 | 2.2 | GO:0043140 | ATP-dependent 3'-5' DNA helicase activity(GO:0043140) |
0.6 | 38.1 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.6 | 1.7 | GO:0004142 | diacylglycerol cholinephosphotransferase activity(GO:0004142) |
0.5 | 1.6 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.5 | 2.7 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.5 | 3.3 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
0.5 | 7.6 | GO:0008373 | sialyltransferase activity(GO:0008373) |
0.5 | 1.6 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.5 | 10.8 | GO:0098531 | RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding(GO:0004879) transcription factor activity, direct ligand regulated sequence-specific DNA binding(GO:0098531) |
0.5 | 4.9 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.5 | 1.6 | GO:0071553 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
0.5 | 2.6 | GO:0001595 | angiotensin receptor activity(GO:0001595) angiotensin type II receptor activity(GO:0004945) |
0.5 | 1.6 | GO:0002060 | purine nucleobase binding(GO:0002060) |
0.5 | 7.9 | GO:0015026 | coreceptor activity(GO:0015026) |
0.5 | 10.5 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.5 | 3.7 | GO:0030276 | clathrin binding(GO:0030276) |
0.5 | 1.6 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.5 | 2.1 | GO:0035242 | protein-arginine omega-N asymmetric methyltransferase activity(GO:0035242) |
0.5 | 1.5 | GO:0001968 | fibronectin binding(GO:0001968) |
0.5 | 1.5 | GO:0015199 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
0.5 | 2.0 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.5 | 1.5 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
0.5 | 1.5 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.5 | 1.5 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
0.5 | 50.0 | GO:0005267 | potassium channel activity(GO:0005267) |
0.5 | 4.8 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.5 | 8.2 | GO:0032947 | protein complex scaffold(GO:0032947) |
0.5 | 1.4 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.5 | 3.8 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.5 | 4.2 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.5 | 1.9 | GO:0051400 | BH domain binding(GO:0051400) |
0.5 | 2.8 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.5 | 46.1 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.5 | 4.6 | GO:0004864 | protein phosphatase inhibitor activity(GO:0004864) |
0.5 | 1.4 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.5 | 1.4 | GO:0042156 | obsolete zinc-mediated transcriptional activator activity(GO:0042156) |
0.5 | 1.4 | GO:0030274 | LIM domain binding(GO:0030274) |
0.4 | 1.8 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.4 | 4.4 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.4 | 0.9 | GO:0031013 | troponin I binding(GO:0031013) |
0.4 | 0.9 | GO:0004977 | melanocortin receptor activity(GO:0004977) |
0.4 | 6.2 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
0.4 | 0.9 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.4 | 1.3 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
0.4 | 0.9 | GO:0015651 | quaternary ammonium group transmembrane transporter activity(GO:0015651) |
0.4 | 1.3 | GO:0004844 | uracil DNA N-glycosylase activity(GO:0004844) deaminated base DNA N-glycosylase activity(GO:0097506) |
0.4 | 1.3 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
0.4 | 2.2 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.4 | 2.6 | GO:0042895 | tetracycline transporter activity(GO:0008493) antibiotic transporter activity(GO:0042895) |
0.4 | 1.3 | GO:0031708 | bombesin receptor binding(GO:0031705) endothelin B receptor binding(GO:0031708) |
0.4 | 5.1 | GO:0017046 | peptide hormone binding(GO:0017046) |
0.4 | 1.3 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
0.4 | 8.3 | GO:0070405 | ammonium ion binding(GO:0070405) |
0.4 | 0.8 | GO:0004873 | asialoglycoprotein receptor activity(GO:0004873) |
0.4 | 0.4 | GO:0031782 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
0.4 | 5.4 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.4 | 3.7 | GO:0016565 | obsolete general transcriptional repressor activity(GO:0016565) |
0.4 | 5.3 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.4 | 0.8 | GO:0035014 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) |
0.4 | 2.8 | GO:0070325 | lipoprotein particle receptor binding(GO:0070325) |
0.4 | 2.8 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.4 | 5.9 | GO:0016411 | acylglycerol O-acyltransferase activity(GO:0016411) |
0.4 | 0.4 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.4 | 27.8 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.4 | 5.8 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
0.4 | 3.1 | GO:0052866 | phosphatidylinositol phosphate phosphatase activity(GO:0052866) |
0.4 | 2.7 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.4 | 2.7 | GO:0017022 | myosin binding(GO:0017022) |
0.4 | 11.5 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.4 | 8.1 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.4 | 2.2 | GO:0004331 | fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) |
0.4 | 1.1 | GO:0070576 | vitamin D 24-hydroxylase activity(GO:0070576) |
0.4 | 1.1 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
0.4 | 2.9 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
0.4 | 0.7 | GO:0036137 | kynurenine-oxoglutarate transaminase activity(GO:0016212) kynurenine aminotransferase activity(GO:0036137) |
0.4 | 1.8 | GO:0003691 | double-stranded telomeric DNA binding(GO:0003691) |
0.4 | 3.9 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
0.4 | 1.4 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
0.3 | 1.4 | GO:0005497 | androgen binding(GO:0005497) |
0.3 | 0.7 | GO:0008545 | JUN kinase kinase activity(GO:0008545) |
0.3 | 6.2 | GO:0004890 | GABA-A receptor activity(GO:0004890) GABA receptor activity(GO:0016917) |
0.3 | 1.4 | GO:0033613 | activating transcription factor binding(GO:0033613) |
0.3 | 1.0 | GO:0030151 | molybdenum ion binding(GO:0030151) |
0.3 | 0.7 | GO:0035197 | siRNA binding(GO:0035197) |
0.3 | 3.4 | GO:0042562 | hormone binding(GO:0042562) |
0.3 | 0.7 | GO:0051636 | obsolete Gram-negative bacterial cell surface binding(GO:0051636) |
0.3 | 2.3 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
0.3 | 2.0 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.3 | 23.6 | GO:0003777 | microtubule motor activity(GO:0003777) |
0.3 | 3.5 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.3 | 3.5 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.3 | 3.8 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.3 | 1.3 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.3 | 7.5 | GO:0017048 | Rho GTPase binding(GO:0017048) |
0.3 | 0.9 | GO:0001848 | complement binding(GO:0001848) |
0.3 | 2.8 | GO:0005024 | transforming growth factor beta-activated receptor activity(GO:0005024) |
0.3 | 4.9 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.3 | 3.4 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.3 | 0.6 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
0.3 | 1.5 | GO:0015355 | secondary active monocarboxylate transmembrane transporter activity(GO:0015355) |
0.3 | 5.6 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.3 | 0.9 | GO:0052743 | inositol tetrakisphosphate phosphatase activity(GO:0052743) |
0.3 | 0.9 | GO:0019966 | interleukin-1 binding(GO:0019966) |
0.3 | 51.6 | GO:0003779 | actin binding(GO:0003779) |
0.3 | 1.1 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.3 | 2.6 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.3 | 1.7 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
0.3 | 16.2 | GO:0004497 | monooxygenase activity(GO:0004497) |
0.3 | 18.4 | GO:0000981 | RNA polymerase II transcription factor activity, sequence-specific DNA binding(GO:0000981) |
0.3 | 0.5 | GO:0009975 | cyclase activity(GO:0009975) |
0.3 | 1.4 | GO:0009374 | biotin binding(GO:0009374) |
0.3 | 1.9 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.3 | 4.9 | GO:0003774 | motor activity(GO:0003774) |
0.3 | 2.4 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.3 | 1.1 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
0.3 | 51.5 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.3 | 1.3 | GO:0045502 | dynein binding(GO:0045502) |
0.3 | 0.8 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.3 | 2.6 | GO:0003711 | obsolete transcription elongation regulator activity(GO:0003711) |
0.3 | 6.2 | GO:0005178 | integrin binding(GO:0005178) |
0.3 | 1.3 | GO:0005355 | glucose transmembrane transporter activity(GO:0005355) |
0.3 | 1.8 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.3 | 8.3 | GO:0008009 | chemokine activity(GO:0008009) |
0.3 | 3.5 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
0.2 | 0.2 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.2 | 1.0 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.2 | 1.7 | GO:0008066 | glutamate receptor activity(GO:0008066) |
0.2 | 1.9 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
0.2 | 1.5 | GO:0043498 | obsolete cell surface binding(GO:0043498) |
0.2 | 106.9 | GO:0005509 | calcium ion binding(GO:0005509) |
0.2 | 1.2 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.2 | 1.4 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
0.2 | 0.7 | GO:0015232 | heme transporter activity(GO:0015232) |
0.2 | 1.1 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.2 | 1.4 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.2 | 3.2 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
0.2 | 1.3 | GO:0051635 | obsolete bacterial cell surface binding(GO:0051635) |
0.2 | 0.7 | GO:0016454 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
0.2 | 0.9 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.2 | 0.2 | GO:0043398 | HLH domain binding(GO:0043398) |
0.2 | 3.4 | GO:0003704 | obsolete specific RNA polymerase II transcription factor activity(GO:0003704) |
0.2 | 3.2 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.2 | 15.7 | GO:0005179 | hormone activity(GO:0005179) |
0.2 | 0.2 | GO:0005234 | extracellular-glutamate-gated ion channel activity(GO:0005234) |
0.2 | 0.9 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.2 | 0.6 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.2 | 14.7 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.2 | 0.8 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
0.2 | 1.0 | GO:0004982 | N-formyl peptide receptor activity(GO:0004982) |
0.2 | 0.4 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.2 | 0.6 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.2 | 1.4 | GO:0042301 | phosphate ion binding(GO:0042301) |
0.2 | 0.4 | GO:0017127 | sterol transporter activity(GO:0015248) cholesterol transporter activity(GO:0017127) |
0.2 | 2.6 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
0.2 | 0.6 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
0.2 | 0.6 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
0.2 | 0.2 | GO:0043142 | single-stranded DNA-dependent ATPase activity(GO:0043142) |
0.2 | 0.2 | GO:0005294 | neutral L-amino acid secondary active transmembrane transporter activity(GO:0005294) |
0.2 | 0.2 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.2 | 5.5 | GO:0008146 | sulfotransferase activity(GO:0008146) |
0.2 | 3.4 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.2 | 2.1 | GO:0015926 | glucosidase activity(GO:0015926) |
0.2 | 0.7 | GO:0016594 | glycine binding(GO:0016594) |
0.2 | 0.7 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.2 | 0.4 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.2 | 1.4 | GO:0019841 | retinol binding(GO:0019841) |
0.2 | 1.2 | GO:0004954 | prostanoid receptor activity(GO:0004954) |
0.2 | 1.4 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.2 | 0.3 | GO:0031127 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.2 | 1.0 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.2 | 1.0 | GO:0050839 | cell adhesion molecule binding(GO:0050839) |
0.2 | 0.6 | GO:0004993 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
0.2 | 0.5 | GO:0016149 | translation release factor activity, codon specific(GO:0016149) |
0.2 | 0.9 | GO:0043499 | obsolete eukaryotic cell surface binding(GO:0043499) |
0.2 | 0.6 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.2 | 3.2 | GO:0005496 | steroid binding(GO:0005496) |
0.2 | 3.0 | GO:0016769 | transferase activity, transferring nitrogenous groups(GO:0016769) |
0.2 | 0.2 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
0.1 | 0.4 | GO:0034584 | piRNA binding(GO:0034584) |
0.1 | 0.7 | GO:0008028 | monocarboxylic acid transmembrane transporter activity(GO:0008028) |
0.1 | 0.7 | GO:0048038 | quinone binding(GO:0048038) |
0.1 | 3.4 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.1 | 0.4 | GO:0005310 | dicarboxylic acid transmembrane transporter activity(GO:0005310) |
0.1 | 5.0 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.1 | 14.4 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.1 | 0.3 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.1 | 28.0 | GO:0004930 | G-protein coupled receptor activity(GO:0004930) |
0.1 | 1.2 | GO:0008376 | acetylgalactosaminyltransferase activity(GO:0008376) |
0.1 | 0.4 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.1 | 0.7 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.1 | 1.0 | GO:0008430 | selenium binding(GO:0008430) |
0.1 | 0.6 | GO:0000832 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) |
0.1 | 3.3 | GO:0005262 | calcium channel activity(GO:0005262) |
0.1 | 0.7 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.1 | 0.1 | GO:0070815 | peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
0.1 | 0.6 | GO:0015101 | organic cation transmembrane transporter activity(GO:0015101) |
0.1 | 1.7 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.1 | 0.3 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.1 | 0.5 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.1 | 1.5 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.1 | 3.0 | GO:0020037 | heme binding(GO:0020037) |
0.1 | 0.1 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.1 | 0.3 | GO:0004525 | ribonuclease III activity(GO:0004525) double-stranded RNA-specific ribonuclease activity(GO:0032296) |
0.1 | 1.6 | GO:0016645 | oxidoreductase activity, acting on the CH-NH group of donors(GO:0016645) |
0.1 | 0.2 | GO:0019863 | IgE binding(GO:0019863) |
0.1 | 2.0 | GO:0008236 | serine-type peptidase activity(GO:0008236) |
0.1 | 0.3 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.1 | 0.1 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
0.1 | 0.3 | GO:0043139 | 5'-3' DNA helicase activity(GO:0043139) |
0.1 | 0.9 | GO:0019104 | DNA N-glycosylase activity(GO:0019104) |
0.1 | 0.2 | GO:0005148 | prolactin receptor binding(GO:0005148) |
0.1 | 1.3 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.1 | 0.6 | GO:1901681 | sulfur compound binding(GO:1901681) |
0.1 | 3.6 | GO:0008237 | metallopeptidase activity(GO:0008237) |
0.1 | 0.5 | GO:0016782 | transferase activity, transferring sulfur-containing groups(GO:0016782) |
0.1 | 0.2 | GO:0016208 | AMP binding(GO:0016208) |
0.1 | 0.6 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.1 | 0.5 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.1 | 0.1 | GO:0048020 | CCR chemokine receptor binding(GO:0048020) |
0.1 | 0.6 | GO:0030332 | cyclin binding(GO:0030332) |
0.1 | 0.1 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.1 | 0.3 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
0.1 | 0.1 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
0.1 | 0.3 | GO:0016641 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor(GO:0016641) |
0.1 | 0.3 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.1 | 0.5 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.1 | 0.1 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.1 | 21.3 | GO:0005198 | structural molecule activity(GO:0005198) |
0.1 | 0.7 | GO:0033764 | steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor(GO:0033764) |
0.1 | 0.5 | GO:0016866 | intramolecular transferase activity(GO:0016866) |
0.1 | 8.9 | GO:0008289 | lipid binding(GO:0008289) |
0.1 | 15.4 | GO:0043565 | sequence-specific DNA binding(GO:0043565) |
0.1 | 0.1 | GO:0015301 | anion:anion antiporter activity(GO:0015301) |
0.1 | 1.0 | GO:0000149 | SNARE binding(GO:0000149) |
0.1 | 0.2 | GO:0004661 | protein geranylgeranyltransferase activity(GO:0004661) |
0.1 | 0.6 | GO:0008198 | ferrous iron binding(GO:0008198) |
0.1 | 1.1 | GO:0019842 | vitamin binding(GO:0019842) |
0.0 | 0.0 | GO:0051184 | cofactor transporter activity(GO:0051184) |
0.0 | 0.2 | GO:0036002 | pre-mRNA binding(GO:0036002) |
0.0 | 0.1 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.0 | 0.7 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
0.0 | 1.8 | GO:0015293 | symporter activity(GO:0015293) |
0.0 | 0.5 | GO:0008527 | taste receptor activity(GO:0008527) |
0.0 | 0.2 | GO:0004457 | lactate dehydrogenase activity(GO:0004457) |
0.0 | 0.1 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
0.0 | 0.1 | GO:0032190 | acrosin binding(GO:0032190) |
0.0 | 0.0 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
0.0 | 0.6 | GO:0000049 | tRNA binding(GO:0000049) |
0.0 | 0.1 | GO:0080031 | methyl indole-3-acetate esterase activity(GO:0080030) methyl salicylate esterase activity(GO:0080031) methyl jasmonate esterase activity(GO:0080032) |
0.0 | 0.2 | GO:0004889 | acetylcholine-activated cation-selective channel activity(GO:0004889) |
0.0 | 0.0 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.0 | 0.9 | GO:0005254 | chloride channel activity(GO:0005254) |
0.0 | 0.0 | GO:0030249 | guanylate cyclase regulator activity(GO:0030249) |
0.0 | 0.1 | GO:0004029 | aldehyde dehydrogenase (NAD) activity(GO:0004029) |
0.0 | 0.1 | GO:0004583 | dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity(GO:0004583) |
0.0 | 0.4 | GO:0015002 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors(GO:0016675) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.0 | 0.0 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.0 | 0.1 | GO:0004322 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.0 | 0.1 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.0 | 0.0 | GO:0017159 | pantetheine hydrolase activity(GO:0017159) |
0.0 | 0.0 | GO:0008252 | nucleotidase activity(GO:0008252) |
0.0 | 0.1 | GO:0000175 | 3'-5'-exoribonuclease activity(GO:0000175) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.2 | 31.6 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
3.0 | 44.4 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
2.1 | 82.4 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
1.9 | 1.9 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
1.5 | 25.6 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
1.4 | 39.6 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
1.3 | 38.7 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
1.2 | 15.8 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
1.2 | 30.5 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
1.1 | 24.8 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
1.1 | 34.0 | NABA COLLAGENS | Genes encoding collagen proteins |
1.1 | 168.0 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
1.0 | 4.1 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.9 | 31.6 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.9 | 11.7 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.8 | 12.7 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.8 | 20.6 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.8 | 32.4 | PID BMP PATHWAY | BMP receptor signaling |
0.8 | 4.6 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.8 | 6.8 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.8 | 19.5 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.7 | 26.4 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.7 | 24.8 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.7 | 13.5 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.7 | 8.9 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.7 | 22.8 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.6 | 20.1 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.6 | 7.7 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.6 | 95.4 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.6 | 17.2 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.5 | 6.0 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.5 | 121.8 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.5 | 5.7 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.5 | 14.6 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.5 | 9.0 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.5 | 3.9 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.5 | 2.4 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.5 | 15.9 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.5 | 12.4 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.5 | 4.2 | PID ALK1 PATHWAY | ALK1 signaling events |
0.5 | 6.5 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.5 | 12.4 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.4 | 4.5 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.4 | 0.9 | PID REELIN PATHWAY | Reelin signaling pathway |
0.4 | 8.6 | PID RHOA PATHWAY | RhoA signaling pathway |
0.4 | 2.5 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.4 | 111.9 | NABA MATRISOME | Ensemble of genes encoding extracellular matrix and extracellular matrix-associated proteins |
0.4 | 3.8 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.4 | 0.8 | PID S1P S1P3 PATHWAY | S1P3 pathway |
0.4 | 2.2 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.3 | 3.6 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.3 | 1.0 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.3 | 10.9 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.3 | 6.1 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.3 | 6.2 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.3 | 4.5 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.3 | 4.2 | PID AURORA A PATHWAY | Aurora A signaling |
0.3 | 9.7 | PID LKB1 PATHWAY | LKB1 signaling events |
0.3 | 3.5 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
0.2 | 0.2 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.2 | 4.1 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.2 | 1.9 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.2 | 1.1 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.2 | 2.8 | PID ARF6 PATHWAY | Arf6 signaling events |
0.1 | 5.3 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.1 | 0.1 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.1 | 1.8 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.1 | 3.4 | PID AURORA B PATHWAY | Aurora B signaling |
0.1 | 1.0 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.1 | 0.9 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.1 | 0.9 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.1 | 0.3 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.1 | 0.5 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.1 | 0.4 | PID ENDOTHELIN PATHWAY | Endothelins |
0.0 | 0.6 | PID ARF 3PATHWAY | Arf1 pathway |
0.0 | 0.0 | ST GAQ PATHWAY | G alpha q Pathway |
0.0 | 0.4 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.0 | 0.3 | PID FGF PATHWAY | FGF signaling pathway |
0.0 | 0.2 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.0 | 0.1 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.0 | 0.0 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.0 | 0.0 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.3 | 32.6 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
2.4 | 2.4 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
1.9 | 21.2 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
1.9 | 50.9 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
1.9 | 1.9 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
1.8 | 34.5 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
1.5 | 15.1 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
1.4 | 80.6 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
1.4 | 17.2 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
1.4 | 16.7 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
1.4 | 1.4 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
1.3 | 21.5 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
1.3 | 21.4 | REACTOME GRB2 EVENTS IN ERBB2 SIGNALING | Genes involved in GRB2 events in ERBB2 signaling |
1.3 | 14.4 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
1.3 | 15.3 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
1.3 | 26.7 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
1.2 | 14.3 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
1.2 | 17.7 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
1.2 | 11.7 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
1.1 | 19.5 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
1.1 | 23.2 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
1.0 | 18.4 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.9 | 8.5 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.9 | 19.9 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.9 | 11.2 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
0.9 | 20.9 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.9 | 12.6 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.9 | 4.4 | REACTOME ARMS MEDIATED ACTIVATION | Genes involved in ARMS-mediated activation |
0.9 | 12.2 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.9 | 10.4 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.8 | 16.1 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.8 | 19.1 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.7 | 27.2 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.7 | 11.7 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
0.7 | 1.4 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.7 | 5.3 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.7 | 6.6 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.7 | 6.6 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.6 | 14.9 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.6 | 54.5 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.6 | 5.0 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.6 | 8.1 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
0.6 | 28.2 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.6 | 17.3 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.6 | 9.2 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.6 | 6.7 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.5 | 14.3 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.5 | 11.4 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.5 | 11.3 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.5 | 3.7 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.5 | 7.8 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.5 | 3.6 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.5 | 28.4 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
0.5 | 2.1 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.5 | 6.6 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.5 | 4.1 | REACTOME INCRETIN SYNTHESIS SECRETION AND INACTIVATION | Genes involved in Incretin Synthesis, Secretion, and Inactivation |
0.5 | 6.0 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
0.5 | 6.9 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
0.5 | 1.4 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.5 | 2.9 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.5 | 4.6 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.5 | 0.9 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.5 | 46.9 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.5 | 1.4 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.5 | 5.0 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
0.4 | 3.5 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.4 | 8.0 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.4 | 7.8 | REACTOME FATTY ACYL COA BIOSYNTHESIS | Genes involved in Fatty Acyl-CoA Biosynthesis |
0.4 | 6.9 | REACTOME ACTIVATED POINT MUTANTS OF FGFR2 | Genes involved in Activated point mutants of FGFR2 |
0.4 | 0.4 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.4 | 2.8 | REACTOME REGULATION OF INSULIN SECRETION | Genes involved in Regulation of Insulin Secretion |
0.4 | 4.7 | REACTOME SIGNALING BY NOTCH3 | Genes involved in Signaling by NOTCH3 |
0.4 | 2.0 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.4 | 19.6 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
0.4 | 4.5 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.4 | 2.2 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.4 | 1.8 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.4 | 11.1 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.4 | 1.8 | REACTOME ADP SIGNALLING THROUGH P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |
0.3 | 6.5 | REACTOME L1CAM INTERACTIONS | Genes involved in L1CAM interactions |
0.3 | 2.7 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.3 | 5.2 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
0.3 | 1.0 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.3 | 3.4 | REACTOME PLC BETA MEDIATED EVENTS | Genes involved in PLC beta mediated events |
0.3 | 6.6 | REACTOME ACYL CHAIN REMODELLING OF PC | Genes involved in Acyl chain remodelling of PC |
0.3 | 24.5 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.3 | 1.5 | REACTOME ACTIVATION OF NMDA RECEPTOR UPON GLUTAMATE BINDING AND POSTSYNAPTIC EVENTS | Genes involved in Activation of NMDA receptor upon glutamate binding and postsynaptic events |
0.3 | 5.5 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.3 | 2.0 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.3 | 2.0 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
0.3 | 4.6 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.3 | 2.0 | REACTOME OPIOID SIGNALLING | Genes involved in Opioid Signalling |
0.3 | 4.0 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.3 | 6.4 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.3 | 4.7 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.3 | 0.5 | REACTOME CELL CELL COMMUNICATION | Genes involved in Cell-Cell communication |
0.3 | 38.2 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.3 | 1.6 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.3 | 2.6 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.3 | 1.8 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.2 | 5.5 | REACTOME MUSCLE CONTRACTION | Genes involved in Muscle contraction |
0.2 | 1.7 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.2 | 18.4 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.2 | 2.2 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.2 | 1.8 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.2 | 2.7 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.2 | 0.8 | REACTOME HIV LIFE CYCLE | Genes involved in HIV Life Cycle |
0.2 | 2.4 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.2 | 2.0 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.2 | 3.0 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.2 | 2.0 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
0.2 | 0.5 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
0.2 | 1.5 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.2 | 6.6 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.1 | 4.9 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
0.1 | 0.4 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.1 | 0.3 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.1 | 7.1 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.1 | 1.0 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.1 | 1.0 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.1 | 1.4 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.1 | 2.4 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.1 | 1.2 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.1 | 3.0 | REACTOME TRANSMISSION ACROSS CHEMICAL SYNAPSES | Genes involved in Transmission across Chemical Synapses |
0.1 | 1.0 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.1 | 0.4 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
0.1 | 0.1 | REACTOME OPSINS | Genes involved in Opsins |
0.1 | 1.0 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.1 | 1.0 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.1 | 0.6 | REACTOME LIPID DIGESTION MOBILIZATION AND TRANSPORT | Genes involved in Lipid digestion, mobilization, and transport |
0.1 | 0.5 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
0.1 | 2.0 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
0.1 | 0.2 | REACTOME MRNA CAPPING | Genes involved in mRNA Capping |
0.1 | 2.0 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.1 | 1.2 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.1 | 1.0 | REACTOME PEPTIDE HORMONE BIOSYNTHESIS | Genes involved in Peptide hormone biosynthesis |
0.1 | 0.6 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.1 | 0.2 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.1 | 1.0 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.1 | 0.5 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |
0.1 | 1.0 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.1 | 0.4 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.1 | 1.0 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
0.1 | 0.4 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.0 | 0.5 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.0 | 0.7 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.0 | 1.5 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.0 | 1.7 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.0 | 0.2 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.0 | 0.0 | REACTOME RESOLUTION OF AP SITES VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the single-nucleotide replacement pathway |
0.0 | 0.1 | REACTOME SIGNALING BY FGFR | Genes involved in Signaling by FGFR |
0.0 | 0.2 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.0 | 0.0 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.0 | 0.1 | REACTOME GLYCOSAMINOGLYCAN METABOLISM | Genes involved in Glycosaminoglycan metabolism |